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ABSTRACT 
 
Telomerase is a unique reverse transcriptase that has evolved specifically to 
extend the single stranded DNA at the 3’ ends of chromosomes. To achieve this, 
telomerase uses a small section of its integral RNA subunit (TR) to reiteratively copy a 
short, canonically 6-nt, sequence repeatedly in a processive manner using a complex and 
currently poorly understood mechanism of template translocation to stop nucleotide 
addition, regenerate its template, and then synthesize a new repeat. In this study, several 
novel interactions between the telomerase protein and RNA components along with the 
DNA substrate are identified and characterized which come together to allow active 
telomerase repeat addition. First, this study shows that the sequence of the RNA/DNA 
duplex holds a unique, single nucleotide signal which pauses DNA synthesis at the end of 
the canonical template sequence. Further characterization of this sequence dependent 
pause signal reveals that the template sequence alone can produce telomerase products 
with the characteristic 6-nt pattern, but also works cooperatively with another RNA 
structural element for proper template boundary definition. Finally, mutational analysis is 
used on several regions of the protein and RNA components of telomerase to identify 
crucial determinates of telomerase assembly and processive repeat synthesis. Together, 
these results shed new light on how telomerase coordinates its complex catalytic cycle. 
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CHAPTER 1 
 
INTRODUCTION: AN OVERVIEW OF THE TELOMERASE 
RIBONUCLEOPROTEIN ENZYME 
 
Reproductions with permission in part from: 
 Brown, A.F., J.D. Podlevsky and J.J.-L. Chen (2013) Telomerase: A eukaryotic DNA 
polymerase specialized in telomeric repeat synthesis. In Nucleic Acid Polymerases-1st 
edition, M. Trakselis and K. Murakami, eds., Springer Press. p.215-236. 
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Introduction 
1.1 History and significance of the telomerase enzyme 
 
More than three-quarters of a century ago, Muller and McClintock found that the 
linear chromosomes of eukaryotic organisms required an essential terminal capping 
structure necessary for genomic stability (McClintock, 1941; Muller, 1938).  While 
chromosomes lacking these capping structures, termed ‘telomeres’, were unstable and 
deleteriously affected cell survival, chromosomes with intact telomere structures were 
stable and mainatained genomic integrity (McClintock, 1941).  Over time the function of 
telomeres for chromosome stability, partioning, masking from double-stranded DNA 
repair, and cellular proliferation was elucidated (Blackburn, 2001; Lange, 2002).  The 
function of telomeres for cellular proliferation was of particular interest due to the 
apparent inherent limitation of conventional DNA polymerases for the replication of the 
chromosome termini (Lingner et al, 1995; Olovnikov, 1973; Watson, 1972).  This end-
replication problem, if left unabated results in chromosome uncapping, exposure of 
chromosome ends to double-stranded DNA repair machinery, genomic instability, and 
related deleterious effects upon cellular survival [reviewed in (de Lange, 2009)].   
The cellular solution to the progressive loss of telomeric DNA and eventually 
genetic material is the unique DNA polymerase called telomerase (Greider & Blackburn, 
1985; Greider & Blackburn, 1987). Telomerase is a reverse transcriptase that has become 
specialized for the addition of telomeric DNA repeats to the ends of chromosomes to 
offset the loss after each replication. Unlike traditional RTs, the telomerase enzyme is 
made up of two components required for activity: the telomerase reverse transcriptase 
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(TERT, also known as TRT, Est2) protein and the integral telomerase RNA (TR, also 
known as TER, TERC, TLC1). The TERT protein component is the catalytic unit 
responsible for DNA polymerization, while the TR provides the template for repeat 
addition. Together these two components make up the minimal catalytic core of 
telomerase, though in vivo a variety of accessory proteins are known to associate with 
one or both components for proper telomerase biogenesis, localization, and regulation  
(Egan & Collins, 2010; Fu & Collins, 2003; Kiss et al, 2010; Venteicher & Artandi, 
2009). 
Control of telomerase activity to maintain telomere length is very important, with 
mis-regulation leading to a number of diseases and disorders in humans and other 
species. In humans, the expression of telomerase is tightly regulated, being turned off in 
most somatic cells and only expressed in germ-line and stem cells (Hiyama & Hiyama, 
2007). Without telomerase, somatic cells are effectively limited in their replicative 
capability and repeated replications will eventually lead to entering a stage of senescence 
and ultimately cell death (Hayflick & Moorhead, 1961). Overcoming this limit, most 
often through the reactivation of telomerase, is an important step to the development of 
cancer. As a result, nearly 90% of human cancers show an up-regulation of telomerase 
(Kim et al, 1994). In the opposite extreme, mutations in telomerase or accessory proteins 
that reduce telomerase activity in cells that normally express it can lead to a number of 
human diseases such as Aplastic Anemia, Idiopathic Pulmonary Fibrosis, and 
Dyskeratosis Congenita (Podlevsky & Chen, 2012).  
Despite its short RNA template, telomerase is known to add long tracts of DNA to 
the ends of telomeres with a single binding event (Greider & Blackburn, 1987; Shippen-
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Lentz & Blackburn, 1990). This processive addition is achieved through two distinct 
steps: the enzymatic addition of multiple nucleotides composing a single repeat to the 3’ 
end of the DNA (nucleotide addition processivity) followed by a regeneration of the 
template without full dissociation for multiple additions of the template sequence (repeat 
addition processivity). This two-step processes is unique among polymerases and 
requires a novel mechanism. First, the telomeric DNA must anneal to the 5’ end of the 
RNA template in the TERT active site (Figure 1.1). With the RNA/DNA properly 
positioned, DNA polymerization occurs, reverse transcribing the short RNA template 
onto the 3’ end of the DNA. At the end of the template, telomerase undergoes a unique 
template translocation event to regenerate the template for addition repeat synthesis 
(Figure 1.1). 
 
Figure 1.1: The unique telomerase catalytic cycle. Telomerase functions 
as a conventional reverse transcriptase by synthesizing single-stranded 
DNA onto the ends of a telomeric DNA primer (blue) from an intrinsic 
RNA template (orange), nucleotide addition. Apart from conventional 
polymerases, upon reaching the end of the template, telomerase has the 
capacity to regenerate the template by a complex mechanism of template 
translocation. Following this, an additional round of nucleotide addition 
then proceeds generating longer telomerase products (violet).  
Unsuccessful template translocation terminates the synthesis of additional 
telomeric repeats by product release. 
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1.2 Telomerase Reverse Transcriptase 
 
The protein component of telomerase, TERT, has retained several structural 
features of prototypical reverse transcriptases as well as evolved its own specialized 
structural features. These conserved structural features of telomerase are commonly 
divided into four domains: the telomerase essential N-terminal (TEN) domain, the 
telomerase RNA binding domain (TRBD), the reverse transcriptase (RT) domain, and the 
C-terminal extension (CTE). 
 
Figure 1.2: Structural organization of the catalytic TERT protein. (a) 
TERT is composed of four structural domains: telomerase essential N-
terminal (TEN, blue) domain, telomerase RNA-binding domain (TRBD, 
green), reverse transcriptase (RT, red), and the C-terminal extension 
(CTE, grey). The TEN and TRBD are telomerase-specific, essential for 
template translocation, and not found among conventional polymerases. 
Important motifs are colored similarly in the encompassing domains. (b) 
The crystallized Tribolium castaneum TERT showing major protein 
domains. The Tribolium castaneum TERT protein forms a ring structure 
unseen in other polymerases.  
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 The enzymatic core of TERT has retained many evolutionarily conserved 
structural motifs with conventional reverse transcriptases. This RT domain makes up a 
structural and functional homolog of the “fingers” and “palm” domains of traditional RTs 
and is divided into seven conserved motifs: 1, 2 and A, B, C, D, and E (Figure 1.2A). 
Like other RTs, the fingers domain (motifs 1 and 2) of TERT has been shown through 
biochemical methods to be involved in binding incoming nucleotides and positioning the 
RNA template (Bosoy & Lue, 2001; Gillis et al, 2008; Wyatt et al, 2010). Meanwhile, the 
palm domain (motifs A, B, C, D, and E) contains the catalytic active site for 
polymerization as well as a primer grip region for holding of the telomeric DNA. Similar 
to conventional RTs, the TERT active site contains three absolutely conserved aspartic 
acids (one in motif A and two in motif C) that catalyze nucleotide addition by a two-
metal ion mechanism (Gillis et al, 2008; Lingner et al, 1997; Nakamura et al, 1997). 
Mutation of any of these three conserved aspartic acids leads to completely inactive 
telomerase in vitro and telomere shortening in vivo (Bryan et al, 2000; Counter et al, 
1997; Harrington et al, 1997; Nakayama et al, 1998; Weinrich et al, 1997; Wyatt et al, 
2010). Additionally, an invariant lysine residue in motif D is thought to act as a general 
acid to activate the pyrophosphate leaving group of the incorporated nucleotide 
triphosphate (Sekaran et al, 2010). Mutation of this lysine in telomerase leads to severely 
reduced telomerase activity in vitro (Bryan et al, 2000; Miller et al, 2000; Sekaran et al, 
2010). The primer grip region of motif E has been shown through biochemical assays to 
be important for single stranded DNA binding and telomere maintenance (Peng et al, 
2001; Wyatt et al, 2007). The crystal structure of T. castaneum TERT shows an 
interaction between the primer grip loop and the 3’ end of the DNA strand of the 
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RNA/DNA duplex bound in the active site, presumably facilitating proper alignment of 
the duplex for nucleotide addition  (Mitchell et al, 2010).  
 Diverging from traditional RTs, the TERT RT domain also contains several 
telomerase specific motifs to perform functions unique to telomerase. One such 
conserved feature is a large insertion in the traditional fingers domain of reverse 
transcriptases, dubbed the insertion in fingers domain (IFD). Mutation studies in IFD 
have identified this domain as essential for telomerase repeat addition processivity and 
telomere maintenance (Lue et al, 2003). Structurally, this domain appears to be important 
for proper arrangement of the protein and does not make direct contact with the DNA or 
RNA (Gillis et al, 2008; Mitchell et al, 2010). Another telomerase specific motif, named 
motif 3 due to its location between motifs 2 and A, has been shown to be more directly 
involved in repeat addition. Mutational analysis of this conserved motif showed 
independent effects on both the repeat addition processivity and rate of repeat addition of 
the telomerase enzyme (Xie et al, 2010). Composed of a long α-helix and a flexible linker 
region, motif 3 is positioned to make direct contact with the RNA/DNA duplex bound to 
the active site. Taken together, the structural and biochemical data support a role of motif 
3 in facilitating the strand separation and template realignment of the RNA/DNA duplex 
during template translocation (Xie et al, 2010). 
 Also characteristic of TERT proteins is a long N-terminus that contains two 
telomerase specific domains; the telomerase N-terminal domain (TEN) and the 
telomerase RNA binding domain (TRBD). The TEN domain contains a high affinity 
DNA “anchor” site which specifically binds single-stranded telomeric DNA (Finger & 
Bryan, 2008; Jacobs et al, 2006; Lue & Li, 2007; Romi et al, 2007; Sealey et al, 2010). 
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This binding of the DNA upstream of the 3’ end in the active site is known to prevent 
complete disassociation of the DNA from the enzyme during processive repeat addition 
and thus increases repeat addition processivity (Wyatt et al, 2010). Separate from its 
known DNA binding capability, several residues inside the TEN domain have been found 
to be important for telomerase function. A conserved leucine residue (L14 in T. 
thermophilia) has been shown to have an effect on the rate of repeat addition in ciliates 
even when the primer is tethered to the enzyme, showing an additional role of the TEN 
domain in repeat addition outside of primer retention (Eckert & Collins, 2012; Qiao et al, 
2010; Zaug et al, 2008). In human TERT, mutation of the L14 or L13 residues resulted in 
a drastic decrease in activity without altered RAP, though a double mutation of L14 and 
L13 did show reduced RAP, reinforcing the importance of a leucine residue for 
processivity. The TEN domain also contains a low-affinity RNA interacting domain 
(RID1) which shows interactions with the TR template/pseudoknot domain, though the 
significance of this interaction is currently unknown (Lai et al, 2001; Moriarty et al, 
2004; Podlevsky & Chen, 2012). The high-affinity RNA interacting domain (RID2) is 
contained in the TRBD and is responsible for the major interaction between TERT and 
the TR (Moriarty et al, 2004). As a result, the TRBD is a universally conserved domain 
of TERT proteins. The TRBD can be broken down into three separate conserved regions: 
CP, QFP, and T motifs. Together, these three motifs form a highly helical structure in 
both T. thermophila and T. castaneum crystal structures and make up the major RNA 
binding pocket (Figure 1.2B) (Gillis et al, 2008; Rouda & Skordalakes, 2007). In addition 
to its importance for RNA binding, the T motif has been shown to play a role in repeat 
addition processivity of the telomerase reaction, likely due to its interactions with the 
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RNA backbone of the RNA/DNA duplex when bound to the active site (Drosopoulos & 
Prasad, 2010; Mitchell et al, 2010). While not universally conserved, different lineages 
appear to contain an additional motif in the TRBD, the VSR in humans and CP2 in 
ciliates, which appear to be important for RNA binding in these species (Lai et al, 2002; 
Moriarty et al, 2002). 
 While the C-terminus of the TERT protein, called the C-terminal extension 
(CTE), contains very little sequence homology to traditional RTs, the structure and 
function of the domain remains similar to the “thumb” domain of retroviral RTs (Figure 
1.2B). Functionally, the CTE has been shown to have an effect on telomeric DNA 
binding and telomerase activity and processivity (Hossain et al, 2002). Structurally, the 
CTE undergoes long range protein-protein interactions with the TRBD domain to form 
the characteristic ring-like shape of the TERT protein (Gillis et al, 2008). It has also been 
proposed that the CTE might have interactions with telomerase RNA, bound to the 
TRBD, to strengthen the interface between the two domains and promote proper protein 
folding (Bley et al, 2011). 
 
1.3 Telomerase RNA 
 
Unlike conventional RTs, the telomerase enzyme includes an integral RNA 
component necessary for enzyme activity. In addition to providing the RNA template for 
telomere extension, the TR also contains various other motifs necessary for telomerase 
activity. Unlike the well conserved TERT protein, the TR is remarkably divergent among 
different phylogenetic lineages (Figure 1.3). While different species contain different TR 
motifs, two in particular are universally conserved: the template pseudoknot domain and 
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three-way junction or stem-terminal element (Figure 1.3) (Blackburn & Collins, 2010; 
Brown et al, 2007; Chen & Greider, 2004; Chen et al, 2002; Chen et al, 2000; Lin et al, 
2004). Together, these two domains make up the necessary components for telomerase 
enzymatic activity in vitro, even when added in trans with the TERT protein (Mitchell & 
Collins, 2000; Tesmer et al, 1999). In humans, the TR contains a third major domain 
known as the H/ACA domain (Figure 1.3B) (Chen et al, 2000; Mitchell et al, 1999a; 
Mitchell et al, 1999b). This domain is homologous to that of small nucleolar (sno) and 
small cajal body-specific (sca) RNAs, containing two stem-loops separated by box H and 
box ACA moieties (Jády et al, 2004). In the TR, a complex of four proteins (dyskerin, 
NOP10, NHP2, and GAR1) bind to the H/ACA domain and are required for proper 
biogenesis and localization (Egan & Collins, 2010; Mitchell et al, 1999a; Vulliamy et al, 
2001).   
The secondary and tertiary structure of the TR has provided many useful insights 
into telomerase function. The template/pseudoknot domain functions to properly position 
the RNA template into the active site and define the template boundary. Biochemical and 
structural studies have shown that the pseudoknot forms into a short triple helix which is 
important for proper telomerase activity (Chen & Greider, 2005; Ly et al, 2003; Qiao & 
Cech, 2008; Shefer et al, 2007; Theimer et al, 2005). The exact mechanism of the triple 
helix towards telomerase activity remains poorly understood, though the template and 
pseudoknot are always very close to each other in the secondary structure (Chen et al, 
2000). NMR structural determination has revealed that the P2a and P2b stems between 
the triple helix and the template adopt a sharp kink, due to a conserved five nucleotide 
bulge junction, which might facilitate proper positioning of the template (Zhang et al, 
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2011; Zhang et al, 2010). In the templating region, the 5’ end is used as template for 
telomeric repeat synthesis, while a smaller non-templating section at the 3’ end is used as 
a realignment region where the extended DNA anneals at the start of each repeat 
synthesis. Upstream of the template is a structural template boundary element (TBE) 
which defines the 5’ end of the template sequence. In humans, the TBE is composed of 
helix P1b with the single stranded RNA between the 5’ end of the template and the stem 
determining the template length (Chen & Greider, 2003b). Mutations that disrupt P1b and 
lengthen or shorten the linker region has been shown to alter the normal repeat sequence 
(Chen & Greider, 2003b; Theimer & Feigon, 2006). Also upstream of the template 
pseudoknot domain in human TR is a guanosine-rich 5’ end which is believed to form a 
G-quadruplex structure. The formation of this G-quadruplex structure and association 
with the HEXH box RNA helicase RHAU has been shown increase TR accumulation 
within cells (Lattmann et al, 2011; Sexton & Collins, 2011). 
Another conserved feature of telomerase RNA important for proper enzymatic 
activity is a template distal stem-loop moiety (Figure 1.3). In vertebrate this moiety is the 
CR4/5 domain composed of a three way junction of helices made from conserved stems 
P5, P6, and P6.1 (Blackburn & Collins, 2010; Brown et al, 2007; Chen et al, 2002; Chen 
et al, 2000). The presence of this three way junction structure is necessary for telomerase 
activity both in vitro and in vivo, with disruptions of the stems or even the mutation of 
only two conserved residues in L6.1 enough to eliminate telomerase activity (Bley et al, 
2011; Chen et al, 2002). Cross-linking studies have suggested that interactions between 
the CR4/5 and both the TRBD and CTE of TERT are necessary for proper protein folding 
(Bley et al, 2011).  A three-way junction structure similar to the CR4/5 domain of 
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vertebrates has also been found as a conserved feature of budding yeasts through 
phylogenetic analysis and is also important for telomerase activity in vitro and in vivo 
(Brown et al, 2007). Ciliates, while not possessing a three-way junction structure, have a 
conserved stem-loop IV which is important for TR-TERT interactions and proper 
telomerase function (Figure 1.3A) (Blackburn & Collins, 2010).   
 
Figure 1.3: The conserved core of the highly divergent TR. Known 
secondary structure diagrams for ciliate (A), vertebrate (B), yeast (C), and 
filamentous fungus (D). Conserved pseudoknot domain and distal stem 
loop moieties (green) are highlighted in each group. Template (red) 
regions along with the template boundary elements (TBE, blue) are also 
shown. Additionally, known accessory protein binding sites denoted by 
boxed regions (purple). 
 
Outside of the telomerase elements required for enzymatic activity, telomerase 
RNA also contains a variety of structural motifs for proper biogenesis, processing, and 
localization of the RNA. In vertebrate TR, the 3’ end contains a conserved H/ACA 
domain. Two copies of a protein complex composed of dyskerin, NOP10, NHP2, and 
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GAR1 bind to this domain and facilitate proper RNA maturation, 3’ processing, and RNP 
biogenesis in cells (Kiss et al, 2010; Li, 2008; Mitchell et al, 1999a; Vulliamy et al, 
2006). Two additional conserved moieties are found in a stem-loop of the H/ACA 
domain, a Cajal body localization (CAB box) important for proper RNA localization and 
biogenesis promoting (BIO box) moiety (Egan & Collins, 2012; Mitchell et al, 1999a; 
Reichow et al, 2007; Venteicher & Artandi, 2009).  
Mutations in the TR gene that affect active telomerase levels in the cell have been 
linked to a number of human telomere-mediated diseases such as Aplastic Anemia, 
Idiopathic Pulmonary Fibrosis, and Dyskeratosis Congenita (Alder et al, 2008; Alder et 
al, 2011; Armanios et al, 2007; Dokal, 2003; Du et al, 2009; Fogarty et al, 2003; Marrone 
et al, 2004; Tsakiri et al, 2007; Vulliamy, 2002; Vulliamy et al, 2006; Yamaguchi et al, 
2003). These disorders appear to be caused by haploinsufficiency and the lone functional 
TR allele does not allow for sufficient TR accumulation, leading to reduced telomerase 
levels and telomere shortening (Armanios et al, 2005). Disease mutations tend to locate 
within the three functional domains: template-pseudoknot, CR4/5, and H/ACA domains 
(Podlevsky et al, 2008). Mutations in these regions can disrupt RNA base-pairing and/or 
RNA structure that are important for enzymatic activity or RNA processing and 
accumulation. Such a decrease in telomerase activity or RNA accumulation levels has 
been experimentally observed for many of the noted disease mutations (Alder et al, 2008; 
Alder et al, 2011; Armanios et al, 2007; Cristofari et al, 2007; Fu & Collins, 2003; Ly et 
al, 2005; Theimer et al, 2003; Theimer et al, 2007).  
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1.4 Telomerase Mechanism 
 
 
Figure 1.4: A working model for the telomerase template translocation 
mechanism. (a) Schematic of human telomerase bound to a telomeric 
DNA primer (blue). The TR alignment region (green) is base-paired with 
the 3’-end of the telomeric DNA primer (blue) to form 5 base pairs 
adjacent to the active site (red arrow). The TR template (orange) is 
constrained by flanking sequences bound to the TERT protein, while the 
5’ region of the telomeric DNA is bound to the TEN domain (gray). 
TERT (gray) catalyzes the addition of six deoxyribonucleotides to the 3’ 
end of the DNA primer by reverse transcribing the TR template sequence 
(step 1). After nucleotide addition, a new repeat is generated. After 
reaching the end of the template, the duplex dissociates from the active 
site (step 2). Outside the active site, the RNA/DNA duplex undergoes 
template translocation involving strand separation (step 3) and template 
realignment (step 4a) to reform 5 base pairs (step 5). This reannealed 
duplex can then bind back to the active site for further nucleotide addition. 
Unsuccessful realignment of the DNA primer to the RNA template 
eventually results in complete dissociation of the DNA product from the 
enzyme (step 4b). Strand separation and template realignment (steps 3 and 
4a) are postulated as reversible, with multiple binding/separation steps 
possible. 
 
Due to the unique role of telomerase compared to other polymerases, a novel 
mechanism for telomeric repeat synthesis has evolved. While other RTs bind pre-
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annealed RNA/DNA duplex and use a long RNA template to synthesize DNA in a 
processive manner, telomerase uses single stranded DNA as substrate and uses an 
internal, short RNA template to add multiple repeats of a repetitive sequence in a 
processive manner. The repetitive nature of telomerase extension lends itself to be 
represented as a repeat cycle with 5 distinct steps; nucleotide addition, duplex 
disassociation, strand separation, template realignment, and duplex binding (Figure 1.4).  
 
Nucleotide Addition 
 
The mechanism for polymerization of incoming nucleotides is similar to other 
RTs and employs a two metal ion mechanism. The three invariant aspartic acid residues 
in the palm domain of TERT coordinate two magnesium ions in the active site (Gillis et 
al, 2008). Free nucleotides are bound by the nucleotide binding pocket between the 
fingers and palm domain of the TERT protein and positioned in the active site (Gillis et 
al, 2008).  The RNA/DNA duplex is positioned in the active site by cooperation of many 
regions of TERT with motif T, motif 3, the fingers domain, and the CTE implicated in 
proper duplex alignment (Gillis et al, 2008; Mitchell et al, 2010; Xie et al, 2010). When a 
proper base pairing of the bound nucleotide and the first free templating residue of the 
RNA/DNA duplex is made, the polymerization reaction occurs and a pyrophosphate is 
released. Once polymerization is complete, the RNA/DNA duplex must be moved 
through the active site to place the 3’ end of newly extended DNA into the active site. 
This translocation of the duplex during nucleotide addition has been proposed to be 
facilitated by both the flanking single stranded DNA and RNA through possible 
secondary structure formation in the DNA and stretching or compaction of the bound 
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RNA (Berman et al, 2011; Jarstfer & Cech, 2002). Furthermore, there is evidence in both 
human and yeast that the length of the extended RNA/DNA duplex is maintained at a 
constant, short length of five to seven base pairs by unpairing at the 5’ end of the DNA 
for every new base pair made at the 3’ end (Förstemann & Lingner, 2005; Qi et al, 2012). 
This is supported by the T. castaneum crystal structure where the central cavity of the 
protein is large enough to accommodate a duplex of seven to eight base pairs (Gillis et al, 
2008). The unpairing of base pairs at the 5’ end of the DNA also appears to have 
functional significance in duplex translocation through the active site during processive 
nucleotide addition. When the template region of the TR is deleted and telomerase is 
supplied a preannealed RNA/DNA duplex as substrate, telomerase could only extend a 
short 5 base pair duplex processively if a short 5’ single stranded DNA overhand was 
present and showed a higher affinity to the duplex with the overhang (Qi et al, 2012). 
Together, this data suggests that the TERT protein binds unpaired single stranded DNA at 
the 5’ end to pull the duplex through the active site after nucleotide addition to prepare 
for the next addition. 
Duplex Dissociation 
 
Once telomerase reaches the end of its short template, the duplex must dissociate 
from the active site, the two strands of the duplex must be separated, and then the two 
strands must be realigned at the beginning of the template for subsequence repeat 
additions. To achieve this, there are two major models that telomerase could follow; the 
DNA could remain bound to the active site while the RNA is separated and repositioned 
relative to the DNA or the RNA/DNA duplex could dissociate together and reposition 
outside the active site. Recently,  biochemical data has supported the latter model by 
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showing that the active site of telomerase becomes unoccupied and accessible to a short 
external RNA/DNA duplex during repeat synthesis (Qi et al, 2012). This suggests that 
full dissociation of the RNA/DNA duplex from the active site is the first step of template 
translocation. This is also supported by a comparison between the crystal structures of T. 
castaneum TERT with and without an RNA/DNA duplex bound in the active site. It is 
predicted that the separation of the duplex in the active site would require a significant 
conformation change to break not only the hydrogen bonds of the duplex, but also the 
protein-nucleic acid contacts holding the duplex in the active site. However, breaking 
only the protein-nucleic acid contacts would require far less energy and is more 
consistent with the relatively minor changes in the protein seen between the two crystal 
structures (Gillis et al, 2008; Mitchell et al, 2010). Furthermore, correlation between 
repeat addition rate in mutated telomerases and duplex turnover rates with duplex 
substrates hints that duplex dissociation may be the rate-limiting step of template 
translocation (Qi et al, 2012). In support of full duplex dissociation occurring before 
strand separation, it has been observed in several species that the stability of the 
telomerase with a bound primer is dependent on the sequence of the primer, but did not 
correlate with base pairing between the DNA primer and RNA template (Finger & Bryan, 
2008; Hammond & Cech, 1998; Wallweber et al, 2003). This suggests that protein 
nucleic acid contacts play an important role in stabilizing the RNA/DNA duplex. 
Strand Separation 
 
Once the RNA/DNA duplex dissociates from the active site, the RNA and DNA 
strands must separate from each other and then realign so that the DNA 3’ end is back at 
the beginning of the template region through base pairing with the template alignment 
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region. The method the enzyme employs to separate the two strands in a rapid manner 
remains elusive, though it has been noted that if the duplex is maintained at a short length 
of five to six base pairs, the duplex would separate spontaneously at 37°C in a reasonable 
time scale compared to known repeat addition rates (Qi et al, 2012). Using the nearest 
neighbor thermodynamic parameters, the off rate (koff) of the 6 bp RNA/DNA duplex 
(CUAACC/GGTTAG), can be approximated near 3ms-1 at 37°C, which gives a half-life 
(T1/2) of 0.2ms (Sugimoto et al, 1995; Turner, 2000)(Qi et al, 2012). 
Template Realignment 
 
 Once the two strands are separated, the DNA could completely dissociate from 
the protein, leading to a termination of repeat addition, or it could re-anneal back to the 
template alignment region of the RNA to prepare for another addition. The ratio of DNA 
dissociated to template realignment is called the translocation efficiency and is the 
determinant of telomerase repeat addition processivity. To limit DNA dissociation in 
telomerase with high repeat addition processivity, the telomeric DNA sequence remains 
bound the TEN domain of TERT even while not bound to the central cavity near the 
active site (Finger & Bryan, 2008; Jacobs et al, 2006; Wyatt et al, 2007; Zaug et al, 
2008). This interaction tethers the telomeric DNA to the protein during translocation, 
where the DNA must dissociate from the active site for repeat synthesis. In addition to, or 
perhaps in concert with, the TEN domain anchor site, two telomerase accessory proteins, 
POT1 and TPP1, have been shown to greatly decrease the probability of DNA 
dissociation through direct interactions with both the single stranded DNA and TERT 
protein (Latrick & Cech, 2010; Wang et al, 2007). The POT1-TPP1 complex has also 
been implemented in telomerase recruitment to telomeric DNA which may be related to 
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its processivity promoting function (Latrick & Cech, 2010; Zhong et al, 2012). While the 
DNA is held onto the protein, the free 3’ end can once again find the free RNA template 
and base pair with the template realignment region. Proper repositioning of the template 
and DNA to prevent reannealing to the templating region is aided by steric forces of the 
TR scaffold which stretch and compress in the regions flanking the template (Berman et 
al, 2011).  Once positioned, the efficiency of realignment is determined in part by the 
length of commentary sequence in the realignment region with longer sequences 
producing more processive enzymes (Chen & Greider, 2003a).  
Duplex Binding 
 
Once the DNA realigns with the RNA template, the duplex is then free to rebind 
to the active site for another round of repeat addition. Since the newly formed duplex is 
very short (five nucleotides in humans), it would naturally be very unstable at 37°C. 
Rapid binding of the duplex to stabilize it with protein-nucleic acid contacts before it 
dissociates would then be important for efficient template translocation. In support of 
this, experiments using both duplex substrates and short eight nucleotide primers lacking 
upstream protein interactions to hold them to TERT during translocation showed a strong 
correlation between binding affinity of the substrates and the repeat addition processivity 
of various TERT mutants (Qi et al, 2012; Xie et al, 2010). A strong binding affinity was 
shown to correlate with high translocation efficiency, decreasing the number of products 
which dissociate after repeat addition without going through another cycle (Qi et al, 
2012). This suggests that the duplex binding affinity of TERT is a major determinant of 
repeat addition processivity. It has also been noted that repeat addition processivity can 
be stimulated by the concentration of dGTP, whether by enhancing the rate of addition as 
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in human or the translocation efficiency in Chinese hamster telomerase (Maine et al, 
1999). Experiments in T. thermophila show that this dGTP dependent processivity is not 
due to its role as the first nucleotide incorporated at the beginning of nucleotide addition 
and is unlikely to affect DNA primer retention, leaving the exact mechanism of 
processivity stimulation unknown (Hardy et al, 2001). With the newly realigned duplex 
bound back the TERT active site, it is then in proper position to undergo nucleotide 
addition again to add another telomeric repeat. 
 
1.5 Conclusion 
 
As more becomes known about telomerase, its unique role in Eukaryote biology is 
becoming clearer. In the transition from circular to linear chromosomes, life likely used 
an ancestral single-copy RT gene to extend each chromosome 3’ end to counter act 
progressive DNA loss upon replication. Over time, that ancestral RT evolved to become 
highly specialized in its role of maintaining chromosome ends that would eventually form 
the unique telomere complex. The most notable adaptation is the internalization of the 
RNA template for DNA polymerization in the form of an integral telomerase RNA 
component. While little is known about this ancestral TR due to its highly divergent 
nature through evolution, discovery of new TRs from different phylogenetic groups is 
slowly increasing our understanding of TR evolution. In all TRs discovered to date, a 
core structure has been found composed of a RNA pseudoknot secondary structure in 
close special proximity to the templating region as well as a structural feature used to 
define the 5’ end of the template (Figure 1.3). While the exact function of the pseudoknot 
structure remains elusive, its presence and importance in telomerases from such diverse 
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groups such as ciliate, yeasts, and vertebrates strongly suggests that this structure evolved 
early in the ancestral TR and plays such a vital role in telomerase that it has been 
universally conserved since. Outside the template pseudoknot domain, another important, 
yet less conserved, feature of telomerase is a template distal stem-loop moiety important 
for RNP assembly and telomerase activity. In vertebrates and both budding and fission 
yeasts, this takes the form of a three-way junction structure (Figure 1.3). While sequence, 
structural, and even mutational studies have shown strong homology between the three-
way junction structure of these groups as well as its importance to telomerase activity and 
telomere maintenance, this structure appears far less universal in TR structures and 
functions. While the TR from both budding yeasts K. lactis and S. cerevisiae contains the 
conserved TWJ structure, it appears to be dispensable for telomere maintenance in S. 
cerevisiae while essential in K. lactis like with vertebrates (Brown et al, 2007; Zappulla 
et al, 2005). Despite this, the wide conservation of this structure and the functional 
similarities between yeasts and vertebrates suggests that a TWJ structure was an 
important feature of an ancestral TR before the branching of yeast and vertebrate 
lineages. In the earlier branching ciliates, no TWJ junction structure is found, but a 
conserved and functionally important stem-loop IV shows some similarity. Like the TWJ 
in vertebrates, stem-loop IV in ciliates provides a high affinity binding location to the 
TERT protein and is required for RNP assembly (Robart et al, 2010). However, unlike 
vertebrate TWJ, stem-loop IV appears to have little to no effect on the catalytic function 
of telomerase in the holoenzyme (Robart et al, 2010). In an evolutionary context, it is 
unclear if the TWJ structure in yeasts and vertebrates evolved from a structure more 
similar to the ciliate stem-loop IV after ciliate branched off, or if a loss-of-function 
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removed the TWJ structure of the ancestral TR from ciliates. While the pool of identified 
and characterized TRs is continually growing, ultimately there is a great need in the field 
to expand the reach of this pool into more diverse phylogenetic groups. With more TRs 
from a larger variety of specie groups, we will be able to expand our knowledge of TR 
evolution. 
Unlike the TR, the TERT protein has remained much more conserved, though 
many adaptations have been made to become specialized for its unique biological role. 
Classically, reverse transcriptases are associated with viruses which use them to replicate 
their RNA genomes into a DNA intermediate during infection. Structural and functional 
studies of viral RTs over the decades since their first discovery in 1970 have created a 
solid understanding of a “traditional” reverse transcriptase. More recently, reverse 
transcriptases have been found in not only viruses, but also in bacterial and eukaryotic 
genomes. In eukaryotes, a large and diverse group of RT’s are associated with 
retrotransposons which are self-replicating genetic elements found all throughout 
eukaryotic genomes. In humans, retrotransposon derived sequences make up about 50% 
of the entire genome and are thought to play vital roles in gene regulation (Belfort et al, 
2011). While a diverse group, telomerase shares quite a few similarities with other 
eukaryotic RTs which could shed clues on its evolutionary origin. While most 
retrotransposons use an endonuclease activity to insert its genomic material in the middle 
of the genome, several RTs such as the Penelope-like element (PLE) and long 
interspersed element-1 (LINE-1) have been shown to act in a endonuclease-independent 
mechanism at free DNA 3’ ends in a manner similar to telomerase and even have been 
shown to associate with and act on telomere ends (Kopera et al, 2011). In Drosophila, due 
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to a loss of telomerase at some point in its evolution, several non-telomerase 
retrotransposons have come together to compensate for telomerase loss and created a 
novel method to maintain telomere ends (Pardue & DeBaryshe, 2011). Together, these 
observation suggest a common ancestral RT in early eukaryotes that diverged and 
specialized into retrotransposons and telomerase independently to fulfill distinct 
functional roles. 
1.6 Projects 
 
 While our knowledge of the telomerase enzyme grows each year, there are still 
many gaps in our understanding that need to be filled. As a ribonucleoprotein complex 
which acts on single stranded DNA, there are many independent parts of telomerase that 
must come together to perform its important function. This study aims to identify and 
characterize several novel interactions and pieces of telomerase important for activity, 
processivity, and assembly of the active enzyme.  
 In chapter 2, the interaction between telomerase and the duplex formed from the 
RNA template and telomeric DNA are characterized. Particularly, we examine how the 
sequence of the RNA/DNA duplex affects duplex usage and nucleotide addition. Using a 
template free telomerase system, duplexes with different permutations of the telomeric 
sequence are examined. Several duplex modifications are also used to find the factors in 
the duplex sequence which affect its usage by the telomerase enzyme. 
 In chapter 3, the role of the template sequence in the native template containing 
telomerase is explored. Template sequence permutations and mutations are also 
introduced into the native in vivo reconstituted telomerase enzyme to examine how 
duplex sequence recognition affects the native enzyme and what role it plays in the 
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telomerase reaction. We also explore how other known RNA interactions work in relation 
to the novel sequence dependence found in this study. 
 In chapter 4, mutational analysis is employed to characterize several novel 
residues in the TERT protein and RNA components. A well conserved adenosine residue 
found in the junction of the TWJ region of many TRs was determined through structural 
studies to likely be important for binding of the TWJ to the TRBD region of the TERT 
protein. Mutations of this residue in multiple species showed that this conserved residue 
is indeed important for telomerase activity in all species tested and appears to be a 
conserved mechanism for TWJ binding. Several mutations found in the TERT protein 
and shown to be linked to disease in humans were also studied. Specifically, two motif T 
mutations were discovered to be linked to Hoyeraal Hreidarsson syndrome due to 
decreases in telomerase processivity. We investigated the motif T domain using alanine 
screening to determine the motif’s role in processivity. We then characterized one of the 
disease mutant residues, K570, to determine a possible mechanism for it defects in 
processivity. 
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CHAPTER 2 
 
TELOMERASE RECOGNIZES THE SEQUENCE OF THE RNA/DNA DUPLEX TO 
REGULATE NUCLEOTIDE ADDITION 
Reproduced with permission in part from: 
Qi, X., Xie, M., Brown, A. F., Bley, C. J., Podlevsky, J. D., & Chen, J. J.-L. (2012). 
RNA/DNA hybrid binding affinity determines telomerase template-translocation 
efficiency. The EMBO Journal, 31(1), 150–61. doi:10.1038/emboj.2011.363 
and 
Brown, A. F., Qi, X., Chen, Y., Podlevsky, J. D., Mingyi, X., & Chen, J. J.-L. (2014). A 
Self-Regulating Template in Human Telomerase. PNAS. (In review) 
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2.1 Introduction 
 
The ends of human chromosomes are composed of precise repetitions of a 6-
nucleotide (nt) sequence synthesized by the specialized reverse transcriptase (RT), 
telomerase (Meyne et al, 1989; Moyzis et al, 1988). The telomerase core enzyme is 
minimally composed of the catalytic telomerase reverse transcriptase (TERT) and the 
integral telomerase RNA (TR) components. Human TR (hTR) is a 451-nt RNA 
containing an exceedingly short 11-nt template which encodes for the telomeric DNA 
repeat GGTTAG (Figure 2.1, left). The resulting highly repetitive tract of DNA is bound 
in a sequence-specific manner by the shelterin complex which protects natural 
chromosome termini from end-to-end fusions and other DNA damage responses (Palm & 
de Lange, 2008; Sfeir & de Lange, 2012). High fidelity synthesis of telomeric DNA 
repeats by telomerase is crucial for maintaining telomere function and chromosome 
stability. Appending the termini of telomeres with even single-nucleotide variations in the 
telomeric DNA repeat sequence is sufficient for compromising the protective function of 
the shelterin complex, culminating in deleterious genome instability and cell death 
(Guiducci et al, 2001; Kim et al, 2001; Li et al, 2004; Marusic et al, 1997; Stohr & 
Blackburn, 2008; Stohr et al, 2010; Vulliamy et al, 2006).  
While TR sequences are highly divergent across taxa, the TR template itself is 
highly conserved (Chen et al, 2000; Xie et al, 2008). Within vertebrates, the template 
sequence is conserved as a specific register with the 5’ boundary defined physically by a 
long-ranged based-paired region known as helix P1 (Figure 2.1) (Chen & Greider, 
2003b). Extensive evidence has demonstrated the importance of the specific TR template 
sequence for telomerase enzymatic function, whereby alterations in the template 
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sequence alone changes the rate and processivity of telomeric DNA repeat synthesis 
(Drosopoulos et al, 2005; Förstemann et al, 2003; Gilley & Blackburn, 1996; Gilley et al, 
1995; Qi et al, 2012). Additionally, telomerase has been shown to exhibit differential 
activity toward telomeric DNA primers with permuted sequences (Maine et al, 1999). 
 During telomere repeat synthesis, telomerase catalyzes nucleotide addition to the 
DNA primer which forms a duplex with the RNA template within the active site. Each 
nucleotide addition creates a discrete RNA/DNA duplex sequence inside the binding 
pocket of the catalytic TERT subunit. It has remained elusive how the telomerase active 
site handles this growing and dynamically changing RNA/DNA duplex during processive 
telomeric DNA repeat synthesis. In this study, we investigated how the human telomerase 
active site utilizes its specific RNA template during nucleotide polymerization. By 
employing a telomerase-free telomerase system and specific assay conditions, we 
discovered that hTR is embedded with a single-nucleotide signal to pause nucleotide 
addition at an exact position, defining a template boundary without the canonical P1 
defined structural boundary.  
2.2 Material and Methods 
 
Oligonucleotides and RNA/DNA hybrid substrates  
All RNA and DNA oligonucleotides were purchased from Integrated DNA 
Technologies (IDT). The sequences of oligonucleotides used in each experiment are 
shown in the text or figures. The RNA/DNA duplexes were prepared by adding the RNA 
and complementary DNA oligos at a final concentration of 100 μM in 1x annealing 
buffer (100mM Tris–HCl pH 7.5, 500mM NaCl and 50mM EDTA). Duplex formation 
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was facilitated by incubation at 70°C for 3 min, followed by slowly cooling to room 
temperature.  
Reconstitution of telomerase  
Reconstitution of human telomerase in vitro was carried out in RRL as previously 
described (Xie et al, 2010). Briefly, hTERT was expressed from pNFLAG-hTERT using 
the TnT® T7 Quick coupled transcription/translation kit (Promega) according to the 
manufacturer’s instruction. The hTR fragments, PK-TF (nt 64–184) and CR4/5 (nt 239–
328), were transcribed in vitro, gel purified and added at a final concentration of 1 μM to 
assemble with hTERT in RRL.  
Template-free telomerase activity assay  
To analyze TF telomerases, 1 μL in vitro reconstituted TF telomerase was assayed in a 10 
μL reaction containing 1X duplex reaction buffer (50 mM Tris- HCl, pH8.0, 50 mM KCl, 
2 mM MgCl2, 2 mM DTT and 1 mM spermidine), 50 μM pre-annealed RNA/DNA 
duplex, 2 μM dGTP, 0.165 μM α-32P-dGTP (3000Ci/mmol, 10 mCi/ ml, Perkin-Elmer) 
and 0.5 mM dATP as indicated. The reaction was incubated at 20°C for 60 min and 
terminated by phenol/chloroform extraction, followed by ethanol precipitation. The DNA 
products were resolved on an 18% polyacrylamide/8 M urea denaturing gel, dried, 
exposed to a phosphorstorage screen and imaged on a Bio-Rad FX-Pro phosphorimager. 
The AMV RT duplex assay was identical to the TF telomerase duplex assays with the 
exception of substituting TF telomerase with 0.5 unit of AMV RT enzyme (Promega) and 
the products were analyzed directly by denaturing polyacrylamide gel electrophoresis. 
The size markers for template free duplex assay were prepared in a 10 μL reaction 
containing 1X reaction buffer (100 mM sodium cacodylate, pH 6.8, 1 mM CoCl2 and 0.1 
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mM DTT), 10 μM oligonucleotide as indicated, 10 units of terminal deoxynucleotidyl 
transferase (TdT, Affymetrix) and 0.165 μM α-32P-dGTP (3000Ci/mmol, 10 mCi/ml, 
Perkin-Elmer). The reaction was incubated at 30°C for 5 seconds and terminated by 
addition of 10 μL 2X formamide loading buffer (10 mM Tris-HCl, pH 8.0, 80% 
formamide, 2 mM EDTA, 0.08% bromophenol blue and 0.08% xylene cyanol).  
Duplex competitive inhibition assay  
One microliter of in vitro reconstituted template-free telomerase was assayed in a 
10 μL reaction containing 1X duplex reaction buffer, 50 μM non-extendable duplex 
substrate (competitive inhibitor) as substrate, 2 μM dGTP, 0.165 μM α-32P-dGTP 
(3000Ci/mmol, 10mCi/ ml, Perkin-Elmer). 50 μM of extendable P1 substrate was also 
added to reactions as indicated (+ on gel). The reaction was incubated at 20°C for 60min 
before termination with phenol/chloroform extraction followed by ethanol precipitation. 
The DNA products were resolved on an 18% polyacrylamide/8M urea denaturing gel, 
dried, exposed to a phosphorstorage screen and imaged on an FX-Pro phosphorimager 
(Bio-Rad).  
 
2.3 Results 
 
The duplex sequence defines nucleotide addition pausing.  
To investigate how the telomerase active site interacts with different duplexes, we 
employed a human telomerase lacking the template region from hTR (Qi et al, 2012) and 
examined telomerase activity with pre-annealed RNA/DNA duplexes as substrates 
(Figure 2.1, right). This template-free (TF) telomerase was assayed with six permuted 
RNA/DNA duplexes, P1-P6, that represent the six distinct sequence registers formed 
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during nucleotide addition for the synthesis of a GGTTAG repeat (Figure 2.1B, left). 
Interestingly, TF telomerase exhibited distinct extension patterns and diverse activities 
with each permuted duplex. In the presence of 32P-dGTP, the DNA primers from all 
duplex substrates were extended by only one nucleotide (Figure 2.2, lanes 1, 3, 5, 7 and 
11), aside from P5 which was nearly inactive (Figure 2.2, lane 9). With the addition of 
dATP to the reaction, P1, P2, and P6 were extended by three nucleotides, reaching the 
end of the 3-nt RNA template as expected of a conventional RT (Figure 2.2, lanes 2, 4 
and 12). Unexpectedly, TF telomerase was only able to extend P3 by two nucleotides and 
P4 by a single nucleotide (Figure 2.2, lanes 6 and 8). The same premature pausing was 
also seen with longer templates only when the telomeric sequence was used (Figure 
S2.1). The differences in the extension pattern between these permuted duplexes suggest 
that the duplex sequence alone determines the pausing site during nucleotide addition.  
 
 
Figure 2.1: Schematic comparison of native (left) and template-free 
(right) human telomerases. In the native telomerase, the RNA 
template is tethered to the 5’ P1 helix and the 3’ pseudoknot 
structures. The TF telomerase was reconstituted in vitro with hTERT 
and a 5’ truncated hTR (Δtemp) that lacks the template and the P1 
helix. Substrates for the activity assay are single-stranded DNA for 
native telomerase or a pre-annealed RNA/DNA duplex for TF 
telomerase. 
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Figure 2.2: A single nucleotide in the RNA/DNA duplex signals a pause 
in nucleotide addition with template-free telomerase. (left) Sequences of 
permuted telomeric RNA/DNA duplexes P1-P6 or P4 substitution 
variants. (right) Activity assay of in vitro reconstituted TF telomerase with 
various duplex substrates. Substrates were extended by the enzyme with α-
32P-dGTP in the presence (+) or absence (-) of 0.5 mM dATP as denoted 
above the gel. An α-32P end-labeled 18-mer oligonucleotide was used as a 
loading control (l.c.).  
 
A single base pair in the duplex defines the nucleotide addition pause site.  
We further examined which base pair(s) in the duplex signals for this 
unanticipated nucleotide addition pausing. Transversion substitutions were introduced for 
each base pair in the P4 duplex and each variant was assayed with TF-telomerase (Figure 
2.3A, left). All P4 substitutions retained the pause signal with the exception of P4e, 
which had the first rA:dT base pair changed to rU:dA. P4e permitted the addition of a 
second nucleotide, shifting the pause site from +1 to +2 (Figure 2.3A, lane 12). However, 
P4e did not allow the addition of the third nucleotide, pausing nucleotide addition prior to 
reaching the end of the RNA template. We suspected that the neighboring rA:dT base 
pair in the duplex potentially became a new pause signal. Indeed, transversion 
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substitutions at both rA:dT base pairs completely abolished the sequence-defined pausing 
regardless of sequence permutation tested (Figure 2.3B). Thus, the first rA:dT base pair 
formed in the duplex induced a pause in DNA synthesis after incorporating three 
additional base pairs. 
 
Figure 2.3: A single rA:dT base pair in the RNA/DNA duplex signals a 
pause in nucleotide addition with template-free telomerase. (A) Gel image 
courtesy of Xiaodong Qi. (A-B, left) Sequences of RNA/DNA duplexes 
used. (A-B, right) Activity assay of in vitro reconstituted TF telomerase 
(upper panel) and AMV RT (lower panel) with various duplex substrates. 
Substrates were extended by the enzyme with α-32P-dGTP in the presence 
(+) or absence (-) of 0.5 mM dATP as denoted above the gel. An α-32P 
end-labeled 18-mer (A) or 5-mer (B) oligonucleotide was used as a 
loading control (l.c.). The DNA primer TAGGGTTA (M4) extended by 
one 32P-dGTP with terminal deoxynucleotidyl transferase (TdT) were 
included as size markers.  
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To discern the functional groups in the rA:dT base pair necessary to induce the 
pause in nucleotide addition, we designed variants of duplex P4 with specific functional 
groups modified in the first rA:dT base pair (Figure 2.4, top). The TF telomerase assays 
revealed that transition substitutions, rA:dU, rG:dC, or rP:dT (rP = 2-6-diamino-purine-
ribose), which altered individual functional groups in the major and minor grooves of the 
duplex, had only slight effects on the position of pause site (Figure 2.4, lanes 5-10). 
However, the transversion substitution of the first rA:dT base pair in P4 to rU:dA (P4-
UA) showed a noticeable shift in the pause site (Figure 2.4, lane 3-4). This result suggests 
that any ribonucleotide purine:deoxyribonucleotide pyrimidine base pair, rR:dY, is 
sufficient to signal pausing. Thus, it appears that the telomerase active site does not 
recognize specific functional groups in the signaling rA:dT base pair. Moreover, 
extensive mutagenesis of surface residues in the duplex binding pocket of TERT, 
predicted by homology modeling with the Tribolium castaneum TERT crystal structure, 
failed to identify specific residues responsible for sensing the rA:dT pause signal in 
template free (Figure S2.2). To see if RNA in the nearby pseudoknot could play a role, 
we also tested various pseudoknot truncations for an effect on pause signaling, but no 
such change was observed (Figure S2.3). The apparent lack of specificity for nucleic acid 
functional groups, together with our inability to discern specific sensing residues in 
TERT, suggests an indirect readout of the rR:dY pause signal by the TERT protein.  
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.  
Figure 2.4: A ribonucleotide purine:deoxyribonucleotide pyrimidine base 
pair makes up the sequence defined boundary. (above) Sequences of 
permuted telomeric RNA/DNA duplexes P4 variants with substitutions of 
the first rA:dT base pair. P = 2-6-diamino-purine. (below) Activity assay 
of in vitro reconstituted TF telomerase with variant duplex substrates. 
Substrates were extended by the enzyme with α-32P-dGTP in the presence 
(+) or absence (-) of 0.5 mM dATP as denoted above the gel. An α-32P 
end-labeled 18-mer oligonucleotide was used as a loading control (l.c.).  
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P5 inactivity results from catalysis deficiency 
In addition to the distinct extension patterns, the six permuted RNA/DNA 
duplexes also exhibited markedly different activities with TF-telomerase (Figure 2.2). 
Among the six duplexes, P5 consistently displayed little to no activity with TF- 
telomerase. This is consistent with a previous report that Chinese hamster telomerase 
failed react with a DNA primer ending in the exact register as P5, GGTTAG (Maine et al, 
1999). The inactivity of the P5 duplex with TF telomerase presumably results from the 
inability of telomerase to either bind the P5 duplex or catalyze nucleotide addition onto 
this substrate. To discern the relative binding affinity of P5 to the telomerase active site, 
we performed a competitive inhibition assay with the six permuted telomeric duplexes as 
inhibitors competing against a single duplex substrate for binding to the telomerase active 
site (Figure 2.5). The RNA template for these telomeric duplex inhibitors was blocked 
with an rG residue, preventing incorporation of dGTP and therefore could not be 
extended when bound to the telomerase active site. Thus, the inhibition of telomerase 
activity with the non-telomeric substrate correlates with telomerase binding affinity for 
the duplex inhibitors. Interestingly, all duplex permutations showed fairly similar levels 
of inhibition and did not correlate with observed activities of the P1-P6 duplexes (Figure 
2.5). While a direct measurement of relative Kd values of each duplex is needed to 
confirm these results, they suggest that P5 inactivity may result from inefficient catalysis, 
such as improper positioning of DNA 3’-OH within the catalytic site rather than 
decreased affinity to the active site.  
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Figure 2.5: Competitive inhibition assay of P1-P6 duplex substrates. In 
vitro reconstituted TF telomerase with non-extendable duplex competitor 
variants (P1g-P6g) with or with P1 substrate. Substrates were extended by 
the enzyme with α-32P-dGTP. A 32P end-labeled 15-mer oligonucleotide 
was used as a loading control (l.c.). Quantitation of the relative activity in 
the presence of competitor is displayed below the gel. 
 
Duplex length and DNA overhang effect nucleotide-addition processivity 
In addition to the sequence of the duplex effecting nucleotide addition 
processivity, previous work has shown that the length of a duplex can have drastic effects 
on activity of duplex substrates through enzyme turnover as well as altering nucleotide 
addition processivity (Qi et al, 2012). When examine the nucleotide addition processivity 
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of short RNA/DNA duplexes, a 5 bp duplex substrate could only be extended by a single 
nucleotide regardless of the template length provided (Figure 2.6A, lanes 1-3). In 
contrast, a 6bp hybrid substrate can be extended 2 nt (Figure 2.6A, lanes 4-6). We suspect 
the longer duplex might transiently generate a single-stranded DNA or RNA overhang at 
the duplex end distal the active site. The potential effects of overhangs in the RNA/DNA 
hybrid substrates on nucleotide-addition processivity were assayed with substrates 
containing a 5bp hybrid and either a 3′ RNA or 5′ DNA overhang (Figure 2.6B). The 
duplex substrates with 5′ DNA overhangs were extended by the addition of two 
nucleotides in the presence of dTTP, while the substrate with the 3′ RNA overhangs 
failed to extend beyond a single nucleotide (Figure 2.6B, lanes 4, 6, 8 and 10). This 
suggests that a putative TERT active site proximal anchor site binds the 5′ DNA 
overhang on the 5-bp RNA/DNA hybrid to facilitate nucleotide-addition processivity. In 
addition, the Km
app of the 5-bp substrates with the 2-nt 5′ DNA overhang is ∼5 μM, 
substantially lower than the 15 μM for the substrate with a single nucleotide DNA 
overhang (Figure 2.6C). Thus, the presence of a DNA residue at the −7 position is 
important for binding affinity of the 5-bp RNA/DNA hybrid to the active site (Figure 
2.6C).  
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Figure 2.6: Effect of the RNA/DNA hybrid length and overhangs on Km 
rate and nucleotide-addition processivity. (A) In vitro reconstituted 
template-free telomerase was assayed on ice for 30 min using telomeric 
DNA/RNA hybrids of 5 bp (lanes 1-3) or 6 bp (lanes 4-6). The RNA 
template sequence contains 1, 2, or 3 cytosines as indicated above the gel. 
DNA size markers (5, 6 and 7 nt) were generated by 3’-end labeling of 
DNA oligonucleotides (5’-TAGGG, 5’-TAGGGG, and 5’-TAGGGGG) 
with terminal deoxynucleotidyl transferase and α-32P-dGTP. A 32P end-
labeled 18-nt DNA oligonucleotide was used as the loading control (l.c.).  
(B) Effects of overhangs of RNA/DNA hybrid substrates on nucleotide-
addition processivity. The RNA/DNA hybrid substrates contain a 5 bp 
duplex and a 1–2 nt overhang at either the 5’ DNA (5+d1 and 5+d2) or the 
3’ RNA (5+r1 and 5+r2) end. A 32P end-labelled 15 nt DNA 
oligonucleotide was used as a loading control (l.c.). (C) Km of RNA/DNA 
hybrid substrates with and without overhangs. Sequences and structures of 
the RNA/DNA hybrid substrates are shown. Diagram of RNA/DNA 
hybrid substrate indicating nucleotides important for nucleotide-addition 
processivity (NAP) and Km. 
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Processivity factors POT1 and TPP1 don’t effect RNA/DNA duplex usage 
It has been well established that the telomerase accessory proteins POT1 and 
TPP1 have a drastic stimulatory effect on telomerase processivity (Latrick & Cech, 2010; 
Wang et al, 2007). The primary mechanism for this effect has been suggested to be due to 
delaying the dissociation of single stranded DNA products during processive repeat 
addition (Latrick & Cech, 2010). However, since the affinity of telomerase to its 
RNA/DNA duplex has been shown to be correlated with telomerase processivity, it is 
possible that these accessory proteins might affect how telomerase handles RNA/DNA 
substrates. To test this, we purified recombinant hPOT1 and hTPP1 and tested them with 
both the native and template free telomerase assay for any stimulatory effect on activity 
and processivity. As expected, when added to the native telomerase reaction, TPP1 
showed a slight increase in processivity, but when both POT1 and TPP1 were added the 
processivity increased dramatically (Figure 2.7, lanes 1-3). However, no discernable 
effects were observed when repeated with template free telomerase using a pre-annealed 
RNA/DNA duplex substrate (Figure 2.7, lanes 4-6). This suggests that the processivity 
effects of POT1 and TPP1 are independent of interactions with the RNA/DNA duplex. 
49 
 
 
Figure 2.7: Effect of POT1-TPP1 on duplex binding to template-free telomerase. 
(A) SDS-PAGE analysis of purified POT1 and TPP1 proteins. The hPOT1 
protein was purified from baculovirus infected sf9 cells as described previously 
(Lei et al., 2004). The hTPP1 protein fragment (a.a. 89-334) was expressed in E. 
coli cells and purified as described previously (Wang et al., 2007). Molecular 
weight (in kilodaltons, kDa) of protein marker (lane 1) is indicated to the left side 
of the gel and the size of POT1 (71kDa) and hTPP1N (27kDa) are indicated to 
the right side. (B) Effects of POT1-TPP1 on the activity of template-containing 
and template-free telomerases. Direct telomerase assay was performed in the 
presence of 1 μM TPP1 (lanes 2 and 5) or 1μM POT1-TPP1 (lanes 3 and 6) with 
telomerase in vivo reconstituted from either template containing hTR (lanes 1 to 
3) or template-free hTRΔ1-63 (lanes 4 to 6). The template-containing telomerase 
was assayed with single-stranded DNA primer, while the template-free 
telomerase was assayed with a 7 bp RNA/DNA hybrid substrate. A 32P end-
labeled 15-nt DNA oligonucleotide was used as the loading control (l.c.). (C) The 
Km of template-free telomerase to the 7 bp RNA/DNA hybrid substrate in the 
absence or presence of POT1-TPP1. The template-free telomerase activity assay 
was performed with a substrate concentration of 0 to 450 μM in the absence 
(lanes 1 to 8) or presence (lanes 9 to 16) of 1μM of POT1-TPP1. The activity was 
normalized and plotted against the substrate concentration and the Kmapp was 
determined by the best fit to the Michaelis–Menten equation. Average Kmapp and 
standard deviations were calculated from two independent experiments. 
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2.4 Discussion 
 
Our results shed new insights into the telomerase catalytic site, specifically how 
telomerase handles the RNA/DNA duplex during nucleotide addition. While the process 
of template translocation to regenerate the template has been a hot area of study, 
relatively little attention has been given to the process of nucleotide addition. Taken 
together, the data produced here can be used to create a more detailed model of the 
initiation, continuation, and termination of nucleotide addition in telomerase. In this 
model, a previously annealed RNA/DNA duplex composed of the TR template and the 3’ 
end of the telomeric DNA will bind to the active site, facilitated though interactions 
between a template proximal DNA anchor site and the unpaired single stranded DNA 5’ 
of the duplex. After each nucleotide addition occurs, these single stranded DNA 
interactions help translocate the RNA/DNA duplex through the active site, repositioning 
the newly formed 3’ end into the active site so that subsequent nucleotide addition can 
occur. Nucleotide addition will then continue until telomerase detects an rR:dY base pair 
in the correct position relative to the active site (4 nucleotides away). Once this is 
detected, nucleotide addition terminates by a pausing in polymerization due a defect in 
the catalysis of the P5-like duplex.   
While this data can only support this model in the context of the template free 
telomerase system, the fact that the sequence dependent pause corresponds to the exact 
sequence register of the native telomerase is strong evidence for the relevance of this 
mechanism in the template containing enzyme. A functional sequence dependent 
boundary mechanism is one explanation for why the template sequence register 
5’-GGTTAG-3’ is so well conserved (Chen & Greider, 2003b; Podlevsky et al, 2008). It 
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also would explain why previous experiments which disrupt the P1 defined structural 
template boundary only showed an increase in template boundary read through instead of 
a complete elimination of template definition (Chen & Greider, 2003b). This data 
introduces a completely novel mechanism for regulating nucleotide addition and defining 
a template boundary not seen before in telomerase or other polymerases.  
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CHAPTER 3 
 
NATIVE TELOMERASE USES A TEMPLATE DEPENDENT PAUSING SIGNAL TO 
PRODUCE HOMOGENEOUS TELOMERIC ENDS 
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3.1 Introduction 
 
Unique from traditional reverse transcriptases, the catalytic protein component of 
telomerase (TERT) has coevolved with an integral telomerase RNA component (TR), 
which contains, in part, the RNA template used to extend telomeres. This coevolution of 
protein and RNA has produced a reverse transcriptase which has become specialized in 
adding short DNA repeats onto single stranded telomere ends. However, we have 
recently shown that the telomerase active site has retained the ability to bind double 
stranded RNA/DNA duplex like a conventional reverse transcriptase and that this ability 
is essential to repeat addition processivity in human telomerase (Qi et al, 2012). Our 
investigation revealed that a telomerase enzyme without the templating region of the TR 
could bind and extend an external RNA/DNA duplex with both a telomeric and non-
telomeric sequence. However, while telomerase RNA from diverse species have evolved 
to be drastically different in size and primary sequence, most RNA’s have conserved a 
similar template sequence, encoding for a canonical GGTTAG or similar repeat in most 
studied species (Podlevsky et al, 2008). One theory for this conservation of template 
sequence is the coevolution of telomerase with important telomere binding proteins 
which are specialized to bind T/G rich DNA and help cap the chromosome ends 
(Shakirov et al, 2009). Apart from the function of the telomere, there has been evidence 
that specific templating residues play a greater role in the biochemistry of telomerase 
then just acting as a template for nucleotide addition. Mutation of the RNA template in 
Tetrahymena thermophila revealed that specific templating residues effected enzyme 
fidelity and product dissociation not explainable by its ability to base pair with the DNA 
primer (Gilley & Blackburn, 1996; Gilley et al, 1995). In human telomerase, mutation of 
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the RNA template found that changes in the template sequence could lead to significant 
changes in nucleotide addition rate which, again, could not be attributed solely to the base 
pairing of the RNA template with the DNA primer (Drosopoulos et al, 2005).  
The importance of a well-defined telomere sequence is highlighted by numerous 
studies that show even single-nucleotide variations in the repeat sequence is enough to 
compromise the protective function of the telomeres, culminating in deleterious genome 
instability and cell death (Guiducci et al, 2001; Kim et al, 2001; Li et al, 2004; Marusic et 
al, 1997; Stohr & Blackburn, 2008; Stohr et al, 2010; Vulliamy et al, 2006). Since 
telomerase only uses a short region of its TR as a template, proper definition of the 
template ends is crucial for proper telomere synthesis. TRs from different phylogenetic 
groups have evolved slightly different methods to define their template ends, but is 
usually a RNA structural elements, or template boundary elements (TBE), which 
prevents polymerization past the template boundary (Podlevsky & Chen, 2012). In 
humans, the TBE is composed of a helix formed upstream of the template, called helix 
P1. The length of the single stranded RNA between the 5’ end of the template and the P1 
helix has been shown to define the template end and prevent read through (Chen & 
Greider, 2003b). 
In previous work (chapter 2), we showed that when separated from other protein-
RNA or protein-DNA interactions, template-free telomerase will pause during nucleotide 
addition at the native telomeric end sequence of GGTTAG. These observations suggest 
that telomerase can read the sequence of the telomeric repeat during synthesis to regulate 
its biochemical function. In this study, we seek to investigate how this unique sequence 
dependent pause in nucleotide addition functions in the context of the native, template 
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containing telomerase. We show that the observed sequence dependent pause site works 
cooperatively with the structurally defined template boundary to preclude incorporation 
of non-telomeric nucleotides from residues outside the template region. Additionally, this 
sequence-defined pausing mechanism prevents premature arrest of nucleotide synthesis 
and is the predominate mechanism for generating the characteristic 6-nt ladder banding-
pattern of telomeric DNA products in vitro. In the absence of the pausing signal, 
telomerase stalls nucleotide addition at multiple sites along the template, generating DNA 
products with diverse repeat registers at the termini. Our findings demonstrate a unique 
self-regulating mechanism of the human TR template for high fidelity synthesis of DNA 
repeats. 
 
3.2 Material and Methods 
 
In vitro reconstitution of human telomerase.  
The hTERT protein was expressed in rabbit reticulocyte lysate (RRL) from 
pNFLAG-hTERT plasmid DNA using the TnT T7 Quick coupled kit (Promega) 
following the manufacturer’s instruction. The hTR pseudoknot (32-195 nt) and CR4/5 
(239-328 nt) fragments were in vitro transcribed, gel purified and assembled with hTERT 
in RRL at a final concentration 1.0 μM.  
In vivo reconstitution of human telomerase.  
293FT cells were grown in DMEM medium (Corning) supplemented with 10% 
FBS, 1X Penicillin-Streptomycin-Amphotericin B mix (Lonza) and 5% CO2 at 37°C to 
80–90% confluency. Cells in a 6-well plate were transfected with 0.4 μg of pcDNA-
NFLAG-hTERT, 1.6 μg of pBS-U1-hTR (Cristofari et al, 2007) and 6 μL of Fugene HD 
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transfection reagent (Promega) following manufacturer’s instruction. Cells were 
harvested 48 hours post transfection and homogenized in lysis buffer (10 mM Tris–HCl 
pH 7.5, 200 mM NaCl, 1 mM EGTA, 0.5% CHAPS, 1 mM MgCl2, 10% glycerol, 5 mM 
β-mercaptoethanol and 1x complete protease inhibitor cocktail (Roche)). Fifty microliters 
of cell lysate was combined with 5 μL Anti- FLAG® M2 Magnetic Beads (Sigma) pre-
washed with 1X TBS buffer (50 mM Tris-HCl pH 7.4 and 150 mM NaCl), and incubated 
at 4°C with gentle rotation for 1 hour. The beads were washed three times with 500 μL of 
1X TBS buffer and once with 100 μL 1X telomerase reaction buffer (50 mM Tris-HCl, 
pH 8.0, 50 mM KCl, 3 mM MgCl2, 2 mM DTT and 1 mM spermidine).  
Telomerase activity assay  
For analyzing native telomerase, 5 μL immuno-purified in vivo reconstituted 
telomerase on beads was assayed in a 10 μL reaction containing 1X telomerase reaction 
buffer, 1 μM DNA primer, 1 mM dTTP, 1 mM dATP, 2 μM dGTP, and 0.165 μM α-32P-
dGTP (3000Ci/mmol, 10 mCi/ml, Perkin-Elmer). The reaction was incubated at 30°C for 
60 min and terminated by phenol/chloroform extraction followed by ethanol 
precipitation. The telomerase assay was also performed with 2 pmol of 5’ 32P-end labeled 
primer (TTAGGG)3 without the addition of α-32PdGTP. The DNA products were 
resolved on a 10% polyacrylamide/8 M urea denaturing gel, dried, exposed to a 
phosphorstorage screen and imaged on a Bio-Rad FX-Pro phosphorimager. The size 
markers for telomerase assays were prepared in a 10 μL reaction containing 1X reaction 
buffer (100 mM sodium cacodylate, pH 6.8, 1 mM CoCl2 and 0.1 mM DTT), 10 μM 
oligonucleotide as indicated, 10 units of terminal deoxynucleotidyl transferase (TdT, 
Affymetrix) and 0.165 μM α-32P-dGTP (3000Ci/mmol, 10 mCi/ml, Perkin-Elmer). The 
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reaction was incubated at 30°C for 5 seconds and terminated by addition of 10 μL 2X 
formamide loading buffer (10 mM Tris-HCl, pH 8.0, 80% formamide, 2 mM EDTA, 
0.08% bromophenol blue and 0.08% xylene cyanol). 
Northern blotting  
RNA was extracted from 5 μL immuno-purified in vivo reconstituted telomerase 
on beads with 50 μL 1X SDS elution buffer (25 mM Tris-HCl, pH8.0, 200 mM NaCl, 5 
mM EDTA and 1% SDS) followed by phenol/chloroform extraction and ethanol 
precipitation. Extracted RNA was resolved on a 4% polyacrylamide/8 M urea denaturing 
gel, electrotransferred and UV crosslinked to a Hybond-XL membrane (GE Healthcare). 
The hTR riboprobe and hybridization were performed as previously described (Xie et al, 
2010).  
POT1 exonuclease protection assay 
 The hPOT1 protein was purified from baculovirus infected sf9 cells as described 
previously (Lei et al, 2004; Qi et al, 2012). Prior to exonuclease addition, 32P-end-labeled 
DNA oligonucleotides were incubated at a concentration of ~10 nM in 1x PE reaction 
buffer (50 mM Tris-HCl, pH 8.3, 50 mM KCl, 2 mM DTT, 3 mM MgCl2, and 1 mM 
spermidine) with purified hPOT1 protein at a concentration of 4μM at room temperature 
for 15 minutes. After incubation, 5 U of Exonuclease T (5U/μL, NEB) in 1 x PE reaction 
buffer was mixed with the prebound oligonucleotides and POT1 and incubated at room 
temperature for another 10 minutes. Reaction was terminated by ethanol precipitation. 
Resuspended products were resolved on a 10% polyacrylamide/8 M urea denaturing gel, 
dried, exposed to a phosphorstorage screen and imaged on a Bio-Rad FX-Pro 
phosphorimager. 
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3.3 Results 
 
Native telomerase exhibits sequence-defined pausing 
Within the full-length hTR, the sequence-defined pause site would coincide with 
the physical template boundary. To uncouple and separate the potential sequence-defined 
pause from physical template boundary in native telomerase, we reconstituted telomerase 
in 293FT cells with full-length hTR that contains permuted template sequences which 
would separate the sequence-defined pause site from the physical boundary. Telomerases 
containing permuted template sequences, hTR T1-T6, were immuno-purified from 293FT 
cells and assayed for activity with permuted 7-mer DNA primers which anneal to the 
same position on the template relative to the physical boundary (Figure 3.1, left). The T1-
T6 templates were each flanked at 5’ and 3’ by guanosine residues to further define each 
template region and prevent incorporation of non-telomeric nucleotides from outside the 
template with the omission of dCTP from the reaction. In accordance with the TF-
telomerase results, all template-permuted telomerases demonstrated major sequence-
defined pausing at a position three nucleotides following the first rA:dT base pair (Figure 
3.1, white and red arrowheads). In T2-T6, minor bands corresponding to pausing at the 
physical boundary were visible (Figure 3.1 and Figure 3.2, blue arrowheads). In the 
presence of dCTP, minor bands corresponding to products derived from incorporation of 
non-telomeric DNA from outside the template were visible, indicating that the structure-
defined template boundary, when uncoupled from the sequence-defined pause, is 
insufficient to prevent template boundary bypass (Figure 3.1, compare even and odd 
lanes). The inadequacy of the structure-defined template boundary and the predominate 
pause at the sequence-defined pause site were consistently observed. Since different 
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permutations of primers were used with each of the permuted template telomerases, we 
assayed the same mutants with a single permutation of the telomeric primer (5’-
GGTTAGGG-3’) to ensure that the primers were not the cause of the altered banding 
patterns (Figure 3.2).  As expected, regardless of the primers initial alignment position on 
the template, all mutants showed a major band at the +4 position, corresponding to the 
native template boundary end sequence GGTTAG (Figure 3.2, short primer). Only minor 
bands corresponding to the P1 structurally defined boundary were seen. To be thorough, 
we tested all six template permutations with all six primer permutations and observed the 
same template dependent stops in all combinations (Figure S3.1).  The same experiment 
was repeated using a long 18-mer primer to ensure single stranded DNA binding would 
not affect the results, but the same banding patterns were observed (Figure 3.2, long 
primer). As was done with the template free system, extensive mutagenesis of the TERT 
interior surrounding the duplex binding pocket in search of a TERT interaction 
responsible for duplex sensing were tested for disruption of the sequence defined stop in 
the T4 mutant (Figure S3.2). Unfortunately, none of the mutants tested showed a 
significant difference in the pausing site.   
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Figure 3.1: In vivo reconstituted telomerases with permutated templates 
exhibit sequence-defined nucleotide addition pausing. (left) Sequences of 
the DNA primer and the hTR template variants used. The sequence-
defined pausing sites before (white arrowhead) or after (red arrowhead) 
template translocation are denoted. The pausing sites at structure-defined 
template boundary are also denoted by blue arrowhead. (right) Activity 
assay for telomerase with template permutations. Telomerases 
reconstituted in 293FT cells with full-length hTR containing permuted 
template sequences were assayed with similarly permuted DNA primers in 
the presence (+) or absence (-) of 0.5 mM dCTP. The DNA primer 
AGGGTTA extended by one α-32P-dGTP with TdT was included as a size 
marker (M4). The vector-only transfected cells (Vec, lanes 15-16) were 
included as a negative control. Northern blot (courtesy of Josh Podlevsky) 
for hTR co-immuno-purified with FLAG-tagged TERT is shown under the 
activity gel. T7-transcribed hTR (451 nt) was included as a size marker 
(M). 
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Figure 3.2: Native telomerases with permutated templates exhibit 
sequence-defined nucleotide addition pausing. (left) Sequences of the 
DNA primers and the TR template variants assayed. Permuted templates 
(T1-T6) are flanked by guanosine (g) substitutions and the remaining TR 
(black line) sequence is shown. The sequence-defined pausing site (white 
arrowhead) and the physical template boundary (blue arrowhead) are 
denoted. (right) Activity assay for telomerase template permutation 
mutants. In vivo reconstituted telomerases with full-length hTR containing 
permuted templates were assayed with single-stranded DNA primers. A 
32P end-labeled 7-mer or 15-mer oligonucleotide was used as a loading 
control (l.c.). 
 
Telomerase generates the characteristic 6 nt ladder banding-pattern of DNA 
products presumably by releasing products at the template boundary during processive 
DNA repeat synthesis. However, in light of the coincidence in position of the sequence-
defined pause site and physical template boundary, we investigated which mechanism is 
principally responsible for DNA product release. We employed our uncoupled sequence-
defined pause site and physical template boundary template permutated hTR variants and 
performed a unique product release assay. Telomerases reconstituted in vivo with hTR 
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variants, T1-T6, and FLAG-tagged hTERT were immobilized on beads and assayed with 
a 7-mer DNA primer, 5’-GGTTAGG-3’ (Figure 3.3, left). Following the telomerase 
extension reaction, DNA products remained bound to the immobilized telomerases were 
separated from the released products and analyzed. The results showed that telomerase 
 
Figure 3.3: Products from sequence defined boundary are fully 
released from enzyme during repeat synthesis. (left) Sequences of the 
DNA primer and the hTR template variants used. The sequence-
defined pausing sites before (white arrowhead) or after (red 
arrowhead) template translocation are denoted. The pausing sites at 
structure-defined template boundary are also denoted by blue 
arrowhead. (right) Analysis of bound and released DNA products. In 
vivo reconstituted telomerases (T1-T6) were immobilized on anti-
FLAG beads and assayed with a 7-mer DNA primer. DNA products 
released were separated from those bound to the immobilized enzyme 
and analyzed by gel electrophoresis. A 6-mer 32P end-labeled 
oligonucleotide was added to the reaction mix prior to separation from 
the beads and a secondary 7-mer 32P end labeled oligonucleotide was 
added during phenol/chloroform extraction. Intensity traces of released 
(red) and bound (blue) products from the T6 template mutant are 
shown to the right of the gel. The DNA primer GGTTAGG extended 
by one α-32P-dGTP with TdT was included as a size marker (M6). 
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released DNA products predominately at the sequenced-defined pause site, and also 
evidently at the structure-defined boundary (Figure 3.3, lanes 7-12). Therefore, 
nucleotide addition arrest induced by either mechanism is sufficient for product release. 
Notably, lower molecular weight products had a higher release rate (Figure 3.3, right, T6 
trace lines), likely due to less sufficient interactions between the short DNA primer and 
TERT DNA anchor sites (Finger & Bryan, 2008; Wyatt et al, 2007).  
Processive repeat synthesis does not require sequence-defined pausing 
Precise product release is an important component of processive telomeric DNA 
repeat addition. Since sequence-defined pausing leads to product release, we explored 
whether it also contribute to repeat addition processivity of telomerase. A telomerase 
template mutant 48u49u, which had the pausing signal completely eliminated, was 
analyzed for repeat addition processivity and DNA extension patterns (Figure 3.4). When 
boundary bypass is prevented by the absence of dCTP, template variants, T2 and T6, 
arrested nucleotide addition at the sequence-defined pause site (Figure 3.4, lanes 5 and 7). 
In contrast, the 48u49u mutant paused at multiple sites along the template, producing an 
evenly distributed banding pattern (Figure 3.4, lanes 11 and 12) (Drosopoulos et al, 
2005). This suggests that the sequence-defined pausing mechanism prevents premature 
stalling during nucleotide addition and promotes pausing specifically at the sequence-
defined site. Thus, the sequence-defined pausing is the predominate mechanism for 
generating the characteristic 6 nt ladder banding-pattern of telomerase products. 
Surprisingly, the 48u/49u mutant had a higher level of repeat addition processivity than 
the wild-type enzyme, suggesting that sequence-defined pausing is not essential for 
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telomerase repeat addition processivity (Figure 3.4, lane 11). Similar results were also 
observed when the P1 linker was extended instead of deleted (Figure S3.3). 
 
Figure 3.4: Activity assay of in vivo reconstituted telomerases that lack 
the sequence-defined pausing signal or the P1-defined physical boundary. 
(left) Sequences of the DNA primer and the hTR template variants T1, T2, 
T6, 49u and 48u49u. The sequence-defined pausing site is denoted (red 
hexagon). The P1-defined physical boundary is denoted with blue 
arrowhead. The asterisk (*) denotes that the 49u and 48u49u mutants 
contain additional mutations (55u and 54u55u, respectively) in the primer 
alignment region to permit processive repeat addition. (right) Telomerase 
reconstituted in vivo with hTR variants containing either permuted (T1, T2 
and T6) or mutated (49u* and 48u49u*) templates were assayed with the 
18-mer 32P end-labeled DNA primer (TTAGGG)3 in the presence (+) or 
absence (-) of 0.5 mM dCTP. The sequence- and structure-defined pause 
sites are denoted by red and blue arrowheads, respectively. The secondary 
structure of full-length hTR (1-451) with P1 and truncated hTR (39-451) 
without P1 are shown above the gel. 
 
  In vertebrate TR, a long-range base paired region, termed helix P1, defines the 
physical template boundary by limiting access to the template flanking sequence (Chen & 
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Greider, 2003b). The complete removal of the P1 helix did not impair telomerase 
processivity, when boundary bypass was prevented by the omission of dCTP from the 
reaction, and the template variants, T2 and T6, paused nucleotide addition at the expected 
positions (Figure 3.4, lanes 13, 15, 17, 19 and 21). However, in the presence of dCTP, the 
addition of non-telomeric nucleotides from outside the template boundary drastically 
impaired telomerase processivity (Figure 3.4, lanes 14, 16, 18, 20 and 22). Therefore, 
while important for defining the template boundary, tethering the template to the P1 helix 
is however not necessary for telomerase repeat addition processivity so long as the non-
telomeric nucleotide incorporation is prevented. 
POT1 requires exact telomeric repeats at the 3’ end of DNA to protect from exonucleases 
With such a unique sequence dependent mechanism to produce uniform telomeric 
ends, it is likely that there is an important biological function for these uniform ends. As 
expected from our findings, telomerase-positive cells have been shown to have a higher 
frequency of the GGTTAG register at chromosome termini compared to other 
permutation registers (Sfeir et al, 2005). Since a primary biological function of the short 
telomeric repeats at the ends of chromosomes is to bind shelterin proteins to protect the 
ends, we looked at the POT1 shelterin protein for its interactions with telomeric ends of 
different sequence registers. It has already been shown that POT1 binds with high 
specificity to the 10 nucleotide permutation of telomeric sequence 5′-TTAGGGTTAG 
(Lei et al, 2004). If the telomere end is even a single nucleotide short of this register, 
POT1 will not bind well to the extreme termini of the chromosome leaving a 10 nt 
overhang at the 3’ end that could be recognized by DNA damage response proteins. 
However, if the extreme chromosome termini is a few nucleotides longer than the POT1 
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binding sequence, it is unknown if POT1 can protect a short overhang beyond its binding 
site. To test this, we assayed POT1 bound to telomeric oligonucleotides of various 
lengths for its ability to protect the oligonucleotides from exonuclease digestion (Figure 
3.5). As expected from previous data, the 11-mer oligonucleotide which was one 
nucleotide short of the POT1 binding sequence was not protected from the exonuclease 
due to no POT1 binding (Figure 3.5, lanes 13-15). With all other oligonucleotides tested, 
POT1 was able to protect only a single nucleotide past its canonical binding sequence and 
any overhang longer was chewed back by the exonuclease (Figure 3.5, lanes 1-12). These 
results show that POT1 has very limited ability to protect telomere ends behind its 
canonical binding site and even a couple nucleotides beyond can lead to exposed DNA 
ends. 
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Figure 3.5: Protection of telomeric DNA ends through POT1 protection. 
32P-end-labeled oligonucleotides (above) were incubated were incubated 
either with or without hPOT1 (+ or -) and further incubated either with or 
without Exonuclease T (+ or -). Blue background of oligonucleotides 
show expected POT1 binding site. An 18-mer 32P-end-labeled 
oligonucleotide was added after the reaction was completed to act as a 
loading control (l.c.). 
 
3.4 Discussion 
 
Telomerase synthesizes telomeric DNA repeats by iteratively copying the intended 
template sequence from an integral RNA component. The template region from the vastly 
larger TR must be precisely defined to avoid incorporation of non-telomeric nucleotides 
from the template flanking region. The sequence-defined pausing mechanism we have 
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discovered in human telomerase provides new insights into the template boundary 
definition mechanism for vertebrate telomerase. In our current working model of the 
telomerase catalytic cycle, the single-residue sequence-defined pause signal functions 
synergistically with the structure defined template boundary. Following the processive 
addition of six nucleotides to the DNA primer, the first rA:dT base pair in the duplex 
signals a pause in DNA synthesis at the end of the template region which is redundantly 
safeguarded by the P1 helix (Figure 3.6, step a). This pausing permits RNA/DNA duplex 
dissociation from the active site (Figure 3.6, steps b-d). Our model explains the high 
fidelity by which telomerase synthesizes exact 6-nt DNA repeats, allowing complete 
product release and template translocation selectively at the end of template.  
 
Figure 3.6: A model of the telomerase sequence-defined catalytic cycle. A 
duplex of the RNA template and DNA primer is bound to telomerase. 
Nucleotide addition (step a) proceeds, specified by the template sequence. 
After addition of three nucleotides past the pause signal (red), nucleotide 
addition is arrested. Duplex disassociation (step b) leads to an unbound 
duplex with 5’ DNA overhang bound to the TERT anchor site. The strand-
separation of RNA/DNA duplex results in either complete DNA product 
release (step c) or template translocation (step d) that aligns and 
regenerates the template/primer duplex bound by TERT, ready for further 
nucleotide addition (return to step a). 
 
In a processive telomerase reaction, RNA/DNA duplexes formed immediately 
prior to and following template translocation have the sequence register GGTTAG, which 
is identical to the P5 duplex (chapter 2). In the context of TF telomerase, we previously 
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showed that the P5 duplex is inactive, despite the presence of a DNA 5’ overhang. 
However, the processive addition of DNA repeats by native telomerase indicates that the 
P5 duplex formed after template translocation is extended. Moreover, telomerase 
reconstituted with full-length template-permuted hTR T5 is active with the DNA primer 
GGGTTAG which forms a P5-like duplex with the RNA template (Figure 3.2). 
Therefore, in the context of native telomerase, additional mechanisms are required for 
telomerase to extend the P5 duplex following template translocation. When comparing 
TF and template-containing telomerases, the principle difference is the tethering of the 
RNA template to the core enzyme. It has been previously proposed for Tetrahymena 
telomerase that changes in the tension of the 5’ and 3’ template-flanking RNA regions 
during nucleotide addition facilitates proper template translocation (Berman et al, 2011). 
However, human telomerase variants lacking the P1 helix retained processive repeat 
addition when template boundary bypass was prevented (Figure 3.4, lane 13). This is 
consistent with a previous report that mouse telomerase with a longer template is 
processive despite the lack of a P1 helix (Chen & Greider, 2003b). These observations 
suggest that the 3’ template-flanking RNA linker is responsible for telomerase activity 
with the P5 duplex. Potentially, this 3’ template-flanking linker is in a stretched state 
following template/primer realignment, which then promotes correct positioning or stable 
binding of the P5 duplex to the telomerase active site, reinitiating nucleotide addition. It 
is also conceivable that differences in the template-flanking regions prior to and 
following template translocation induce conformational changes in telomerase for 
extending the P5 duplex. Future studies are necessary to explore each of these putative 
mechanisms for P5 activity in native telomerase.  
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Comparative studies of the sequence-defined pausing in telomerases from various 
species also provides insights into the fundamental differences in TR template boundary 
elements between vertebrates/invertebrates and other species. Sequence-defined pausing 
is conserved in vertebrate and invertebrate telomerases, while not found in ciliate or 
fungal telomerases (Figure S3.4). The lack of this sequence-defined pausing mechanism 
in ciliate and fungal telomerases is presumably offset by their distinct and more robust 
structure-defined template boundaries. Ciliate and fungal TR templates have boundaries 
rigidly defined by protein binding and immediately adjacent helical structures, 
respectively (Lai et al, 2002; Miller et al, 2000; Qi et al, 2013; Tzfati et al, 2000). 
Vertebrate and invertebrate TR templates are tethered by a flexible linker to the distal P1 
helix (Chen & Greider, 2003b; Li et al, 2013). The vertebrate/invertebrate P1-tethering 
mechanism appears less stringent in defining the template boundary which necessitates 
an ancillary mechanism, such as sequence-defined pausing, to facilitate precise synthesis 
of telomeric DNA repeats.  
The sequence-defined pausing mechanism potentially explains the higher degree 
of TR template sequence conservation in vertebrate and invertebrate species (Chen et al, 
2000; Podlevsky et al, 2008; Qi et al, 2013). The sequence-defined pause generates the 
exact GGTTAG register at the chromosome termini, evident by the characteristic 6-nt 
ladder banding pattern of telomerase-generated DNA products in vitro. Consistent with 
this finding, a previous study reported that telomerase-positive cells exhibit a markedly 
higher frequency of the GGTTAG register at chromosome termini (Sfeir et al, 2005), 
implying there is a biological significance for the terminal GGTTAG sequence in vivo. 
Moreover, the telomeric DNA motif bound and protected by the single-stranded 
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telomeric DNA binding protein, POT1, also ends with GGTTAG (Lei et al, 2004). 
Leaving even a couple nucleotide overhang past the POT1 binding site can expose the 
single stranded DNA to harmful proteins such as exonucleases (Figure 3.5) The 
conservation of terminal register GGTTAG as the product of telomerase DNA synthesis 
and as the moiety bound by POT1 implies a functional connection and potential co-
evolution between telomerase and POT1, whereby telomerase synthesizes DNA with the 
specific terminal repeat for precise binding by POT1.  
Our findings shed light on the mechanism behind the conservation of the 
vertebrate TR template for synthesizing the specific GGTTAG sequence register (Chen et 
al, 2000) and the acutely deleterious effects from template mutations that impair the 
sequence-defined pausing mechanism (Drosopoulos et al, 2005; Stohr et al, 2010). The 
fidelity of telomeric repeat synthesis by telomerase is crucial for telomere function and 
genome stability in germ line and stem cells as well as in cancer. This sequence-defined 
pausing mechanism is a novel attribute of human telomerase to self-define the template 
region from adjacent sequences, ensuring the synthesis of exact GGTTAG repeats with 
exquisitely high fidelity, thereby contributing to genome stability. 
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CHAPTER 4 
NOVEL PROTEIN AND RNA RESIDUES AND INTERACTIONS IMPORTANT FOR 
TELOMERASE ACTIVITY AND PROCESSIVITY 
 
Reproduced with permission in part from: 
Huang J., Brown A. F., Wu J.,  Xue J., Bley C. J., Rand D. P. , Wu L., Zhang R., Chen J. 
L., & Lei M. (2014) Structural Basis for Protein-RNA Recognition in Telomerase. Nature 
structural & molecular biology. (In Press) 
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4.1 Introduction 
 
While the telomerase enzyme functions to catalyze the polymerization of DNA 
using an RNA template like a traditional reverse transcriptases, its very specific 
biological role has caused telomerase to evolve several unique differences that set it apart 
from any other known reverse transcriptase. One of the most significant of these 
differences is that telomerase has evolved into a ribonucleoprotein which minimally 
requires both the catalytic protein component (TERT) and the template containing RNA 
subunit (TR) to function (Greider & Blackburn, 1987). In addition to providing the 
template for DNA synthesis, the TR subunit of telomerase contains multiple structural 
domains important for catalytic activity, localization in the cell, and assembly of 
important assembly proteins (Podlevsky & Chen, 2012). Unlike the relatively well 
conserved TERT protein, the TR is wildly divergent sequence, size, and structure 
between different phylogenetic groups (Podlevsky et al, 2008).  Despite this divergence, 
several conserved structures have been identified in a variety of distantly related species 
that are important for telomerase function. These include a pseudoknot-template domain, 
composed of a pseudoknot RNA structure with a unique triple helix in close spatial 
proximity to the templating region, and a distal stem-loop moiety, usually consisting of a 
three-way junction structure (Chen & Greider, 2004; Qi et al, 2013).  To accommodate 
this new RNA subunit, the TERT protein had to co-evolve with the RNA and develop 
new domains to recognize and bind specific conserved structural regions of the divergent 
RNA.  
Another significant difference between telomerase and conventional reverse 
transcriptases is the novel property of telomerase to reiteratively copy a short region of its 
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RNA template in a processive manner. This distinctive property of telomerase is known 
as its repeat addition processivity. While this property has been fairly well studied in 
vitro, it was previously unclear how significant it was in vivo. While telomerase from 
nearly all phylogenetic groups currently known have been shown to be processive, there 
are several key examples of telomerase which have little to no processivity in vitro such 
as yeasts K. lactis and S. cerevisiae and vertebrates such as mouse (Cohn & Blackburn, 
1995; Fulton & Blackburn, 1998; Prowse et al, 1993). Recently, several novel human 
TERT mutations have been linked to human diseases and the primary defect caused by 
these mutations were found to be in its repeat addition processivity (Alder et al, 2011; 
Gramatges et al, 2013). These findings indicate that unlike yeasts or rodents, human 
telomerase required high repeat addition processivity to properly maintain telomere 
length in vivo.  
In this study, we set out to use mutagenesis of the TERT and TR subunits to 
characterize various novel protein and RNA residues for their role in telomerase activity. 
In particular, we identify and characterize a universally conserved adenosine residue in 
the junction of the TWJ in vertebrate and fungal TRs. We also employ mutagenesis of the 
human motif T in hTERT to elucidate the role of motif T in repeat addition processivity 
observed with the disease mutants T567M and K570N. 
 
4.2 Material and Methods 
 
Native Telomerase activity assay  
To test the activity and processivity of the telomerase mutants, we expressed each 
of them in vitro and quantified function using a direct telomerase activity assay as 
79 
 
previously described (Xie et al, 2010). All telomerase variants were reconstituted using 
the TnT (transcription and translation) Quick Coupled rabbit reticulocyte lysate system 
(Promega) following manufacturer’s instructions. Briefly, recombinant N-FLAG tagged 
hTERT was expressed in 10 µL of TNT lysate at 30°C for 60 minutes. To obtain active 
telomerase, in vitro transcribed hTR pseudoknot (nt 32–195) and CR4-CR5 (nt 239–328) 
fragments were each added to a concentration of 1 µM and incubated at 30°C for 30 
minutes. To assay the activity and processivity of each telomerase variant, a 10 µl 
reaction was carried out using 3 µl of in vitro reconstituted telomerase in the presence of 
1x PE buffer (50 mM Tris-HCl, pH 8.3, 50 mM KCl, 2 mM DTT, 3 mM MgCl2, and 1 
mM spermidine), 1 μM DNA primer, 0.5 mM dTTP, 0.5 mM dATP, 5 μM dGTP, and 
0.165 μM α-32P-dGTP (3000Ci/mmol, 10 mCi/ml, Perkin-Elmer) at 30°C for 1 h. 
Reactions were terminated by phenol-chloroform extraction followed by ethanol 
precipitation before being resolved on a 10% denaturing polyacrylamide gel.  
Template free telomerase activity assay 
The hTERT protein was expressed in rabbit reticulocyte lysate (RRL) from pNFLAG-
hTERT plasmid DNA using the TnT T7 Quick coupled kit (Promega) following the 
manufacturer’s instruction. The template free hTR pseudoknot (64- 184 nt) and CR4/5 
(239-328 nt) fragments were in vitro transcribed, gel purified and assembled with hTERT 
in RRL at a final concentration 1.0 μM. For the direct assay, 1 μL in vitro reconstituted 
TF telomerase was assayed in a 10 μL reaction containing 1X duplex reaction buffer (50 
mM Tris- HCl, pH8.0, 50 mM KCl, 2 mM MgCl2, 2 mM DTT and 1 mM spermidine), 50 
μM pre-annealed RNA/DNA duplex, 2 μM dGTP, 0.165 μM α-32P-dGTP (3000Ci/mmol, 
10 mCi/ ml, Perkin-Elmer) and 0.5 mM dATP as indicated. The reaction was incubated at 
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20°C for 60 min and terminated by phenol/chloroform extraction, followed by ethanol 
precipitation. The DNA products were resolved on an 18% polyacrylamide/8 M urea 
denaturing gel, dried, exposed to a phosphorstorage screen and imaged on a Bio-Rad FX-
Pro phosphorimager. 
Medaka, S. pombe, and N. crassa telomerase in vitro reconstitution and telomerase 
activity assay  
The medaka, S. pombe and N. crassa telomerases were in vitro reconstituted as 
previously described (Bley et al, 2011; Qi et al, 2013). The TERT protein was 
synthesized in rabbit reticulocyte lysate (RRL) using the TnT Quick Coupled 
Transcription/Translation System (Promega) and then assembled with 1 μM of in vitro 
transcribed RNA fragments in the RRL. Medaka TERT was assembled with medaka TR 
fragments PK (1-150) and CR4/5 (170-220), S. pombe TERT was assembled with S. 
pombe TR fragments T/PK (nt 83–957) and TWJ (nt 1037–1082), while N. crassa TERT 
was assembled with N. crassa TR RNA fragments T/PK (nt 225- 1515, Δ463-
1288/GGAC, Δ256-433/GAAA) and TWJ (nt 1813-1877). The telomerase assay was 
carried out with 2 μL of in vitro reconstituted telomerase in a 10 μL of reaction. For S. 
pombe telomerase assays, the reaction contained 1X reaction buffer [50 mM Tris- HCl 
(pH 8.0), 0.5 mM MgCl2, 1 mM spermidine, 2 mM DTT], 100 μM dATP, 100 μM dCTP, 
100 μM dTTP, 5 μM dGTP, 0.165 μM α-32P-dGTP (3000 Ci/mmol, 10 mCi/ml, 
PerkinElmer) and 1 μM DNA primer 5’-GTTACGGTTACAGGTTACG-3’. For N. 
crassa and Medaka telomerase assays, the reaction contained 1X reaction buffer, 1 mM 
dATP, 1 mM dTTP, 5 μM dGTP, 0.165 μM α-32P-dGTP (3000 Ci/mmol, 10 mCi/ml, 
PerkinElmer) and 1 μM DNA primer 5’-(TTAGGG)3-3’. The reactions were incubated at 
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30°C for 60 min and terminated by phenol/chloroform extraction, followed by ethanol 
precipitation. Telomerase extended products were resolved on a denaturing 8M urea/10% 
polyacrylamide gel. The dried gel was exposed to a phosphor storage screen and analyzed 
with a Bio-Rad FX Pro Molecular Imager.  
 
4.3 Results 
 
The TRBD-CR4/5 recognition mechanism is common to species from yeast to human 
One major obstacle to our understanding of the telomerase enzyme and how the 
protein and RNA work together to synthesis new telomere ends is the low abundance of 
high quality structural information. While a full length TERT-TR co-crystal remains 
elusive in the telomerase field, recent structural studies have been able to isolate specific 
regions of the TERT and TR to produce high resolution structures of these fragments. 
Most recently, a collaborator has been able to obtain a co-crystal of the TERT TRBD 
motif of the Medaka fish telomerase bound to the three-way junction CR4/5 domain of its 
TR using x-ray crystallography (Figure 4.1). Using this high resolution crystal structure, 
many different protein and RNA interactions were identified between the two fragments. 
While some of these interactions had been previously identified as important for RNA-
Protein binding, many were new with no biochemical data as to their role or importance 
to the telomerase enzyme (Bley et al, 2011).  
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Figure 4.1: Overview of the CR4/5-TRBD complex structure. (A) Stereo 
view of the overall structure of the CR4/5-TRBD complex. TRBD and 
CR4/5 are colored in blue and green, respectively. TRBD interacting 
residues U182, G189, and A199 in the CR4/5 are denoted in red.  
 
Among the novel protein-RNA interactions found between the TRBD and CR4/5 
domain, the significance of the interaction with the RNA residue A199 was of particular 
interest. This is because structure-based sequence analysis of all vertebrate CR4/5 and 
yeast TWJ domains clearly shows that junction J6/6.1 invariably contains only a single 
nucleotide, adenine (A199 in medaka CR4/5) (Figure S4.1). Furthermore, the guanine 
residue at the 5’ terminus of junction J5/6.1 (G213 in medaka CR4/5) is also highly 
conserved across species from yeast to human (Figure S4.1). This observation strongly 
suggests that formation of an unusual A•G pair at the junction between stems P6 and P6.1 
is a conserved feature of all CR4/5 and TWJ of TRs, and that the TRBD-CR4/5 
recognition mechanism revealed in the medaka crystal structure is very likely common to 
all species whose TR contains a CR4/5 or TWJ structure. To test this hypothesis, we 
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examined the interaction between TRBD and TWJ from the telomerase of the medaka 
fish and the fission yeast Schizosaccharomyces pombe. Wild-type S. pombe TRBD binds 
to S. pombe TWJ with an affinity comparable to that of the medaka TRBDCR4/ 5 
interaction (Huang et al, 2014). Substitution of the junction nucleotide A199 in medaka 
or A1060 of S. pombe TWJ with any other nucleotide either severely impaired its binding 
to the TRBD or disrupted the folding of TWJ (Huang et al, 2014). To demonstrate the 
effects of these substitutions in the activity of the enzymes, we reconstituted medaka and 
S. pombe telomerase from in vitro generated TERT protein and TR fragments (T/PK and 
TWJ) and examined telomerase activities using a direct primer extension assay. In 
Medaka telomerase, substitutions in the previously identified U182 and G189 produced 
moderate reductions in telomerase activity in vitro while the A199 substitutions produced 
a much more drastic decrease (Figure 4.2A). Titrations of the different CR4/5 RNA 
fragments shows that the decreases in activity is related to defects in the binding of the 
fragments (Figure S4.2). Substitutions in the analogous A1060 residue in S. pombe also 
caused greatly impaired in vitro telomerase activities, suggesting that the junction 
adenine is important for the proper assembly of an active yeast telomerase RNP complex 
(Figure 4.2B). To expand these results, we also examined the TWJ of the filamentous 
ascomycete Neurospora crassa using in vitro reconstituted TERT and TR in our direct 
telomerase assay.  Like with Medaka and S. pombe, substitution of the junction 
nucleotide A1848 with any other nucleotide also led to decreased telomerase activities in 
vitro, although to a lesser extent compared to that of the previous two (Figure 4.2C). 
Notably, an A to G mutation of the junction nucleotide A1130 in TR from the budding 
yeast Kluyveromyces lactis resulted in growth defect and shortened telomere length, 
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indicating that this linker nucleotide is also crucial for telomere function in cells (Brown 
et al, 2007).  
 
Figure 4.2A: Telomerase primer-extension assay of wild type and mutant 
Medaka (O. latipes) telomerases. Activities of mutants are normalized to 
wild type and show below the gel as relative activities. 1 µg of in vitro 
transcribed RNA of each TWJ fragment as run on a 4% PAGE gel and 
visualized below the gel. 
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Figure 4.2B: Telomerase primer-extension assay of wild type and mutant 
S. pombe telomerases. Activities of mutants are normalized to wild type 
and show below the gel as relative activities. 1 µg of in vitro transcribed 
RNA of each TWJ fragment as run on a 4% PAGE gel and visualized 
below the gel. 
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Figure 4.2C: Telomerase primer-extension assay of wild type and mutant 
N. crassa telomerases. Activities of mutants are normalized to wild type 
and show below the gel as relative activities. 1 µg of in vitro transcribed 
RNA of each TWJ fragment as run on a 4% PAGE gel and visualized 
below the gel. 
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Mutation of Motif T residue K570 displays defects in duplex translocation 
Recently, a collaborator identified two disease mutations were in the motif T 
region of the human TRBD: T567M and K570N (Gramatges et al, 2013; Xin et al, 2007). 
Analysis of these mutations reviled that the primary defect caused by these mutations is 
in the repeat addition processivity of telomerase. Unlike previous processivity linked 
disease mutations which were in the catalytic RT domain, these mutations were in a 
region primarily attributed to binding the TR (Alder et al, 2011). However, these results 
were consistent with previous finds that found that a conserved region inside motif T also 
effects rate of repeat addition (Drosopoulos & Prasad, 2010). While these suggest that 
motif T has an involvement in repeat addition processivity, the mechanism by which this 
involvement occurs is still unknown.  
 
 
Figure 4.3: Alanine screening of human motif T with template free 
telomerase. Alanine substitution TERT mutants were reconstituted in vitro 
with template free hTR fragments. RNA/DNA duplex used in the assay is 
shown above the gel. L.C. was a 32P-end-labeled 18-mer DNA primer. 
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To investigate possible roles of this motif in the telomerase reaction, we examined 
its location in the T. castaneum TERT crystal structure in relation to the bound 
RNA/DNA duplex in the active site (Mitchell et al, 2010). The position of motif T in this 
structure makes it unlikely that it can directly interact with the single stranded DNA to 
facilitate template translocation efficiency without significant conformational change. 
However, it is easy to imagine that the small motif could interact with the 5’ single 
stranded RNA template. In an attempt to elucidate any potential interactions between this 
motif and the single stranded RNA template, we created alanine substitution mutants of 
the motif T residues and tested them for activity in our template-free telomerase system 
with an RNA/DNA duplex with a long 5’ RNA overhang (Figure 4.3). While various 
mutations showed different levels of telomerase activity, interestingly the K570A mutant, 
similar to the K570N disease mutant previous described, had dramatically decreased 
nucleotide addition processivity. Like the K570N disease mutant, the K570A substation 
also displayed dramatically decreased repeat addition processivity when tested with 
native template containing telomerase, regardless of the primer used in the assay (Figure 
4.4). Although the K570 mutant does not appear to be significantly worse than the wild 
type enzyme at reaching the end of the first repeat, which requires nucleotide addition 
processivity, the connection between decreased repeat addition processivity in the 
template free system and repeat addition processivity in the native system is interesting.  
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Figure 4.4: Activity assay of K570A telomerase mutant with all 6 permutations of 
telomeric DNA primer. Primers used were all three full repeats of the telomeric sequence 
with the permutation as indicated below the gel. A 15-mer 32P end-labeled 
oligonucleotide was included as a loading control (LC). 
 
To see if any potential single stranded RNA interactions were sequence specific 
or required a certain length of RNA overhang, we tested the K570A mutant with identical 
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RNA/DNA duplexes but with varying template length or sequence (Figure 4.5). While 
the longer template did allow slightly higher nucleotide addition processivity compared 
to the short template, all K570A mutant reactions had drastically impaired processivity 
compared to the wild type enzyme with the same substrate. The consistent impairment in 
nucleotide addition processivity suggests that the K570 residue could be important for 
duplex translocation through the active site and/or proper positioning of the duplex in the 
active site. Our previous work has shown that the sequence of the duplex can also 
produce a drastic difference in nucleotide addition processivity (see chapter 3).  To test 
how the sequence of the duplex affects the activity and processivity of the K570A 
mutant, we tested it with all six circular permutation duplexes in the template free system 
(Figure 4.6). In contrast to wild type TERT, the K570A mutant did not show any 
differences in activity or processivity with any of the duplex sequences. This suggests 
that the mechanism of motif T facilitating duplex translocation is unique from the 
sequence dependent pause seen with the wild type protein. 
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Figure 4.5: Effects of template length and sequence on K570A mutant. 
Template free telomerase composed of either wild type or K570A mutant 
TERT was assayed with three 7 bp RNA/DNA duplexes with varying 
template length and sequence (shown above gel). Addition of 0.5 mM 
dATP and dTTP is denoted below the gel (+). A 32P-end-labeled 5-mer 
was used as a loading control (LC). 
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Figure 4.6: K570A TERT mutant shows defects in nucleotide addition 
processivity using circularly permuted duplex substrates. Template free 
telomerase composed of either wild type or K570A mutant TERT was 
assayed with all 6 circular permutations of the telomeric 7 bp RNA/DNA 
duplex sequence (shown above the gel). Addition of 0.5 mM dATP is 
denoted below the gel (+). A 32P-end-labeled 5-mer was used as a loading 
control (LC). 
 
4.4 Discussion 
 
While our knowledge of the telomerase enzyme and its unique mechanism has 
grown drastically over the last few decades, there are still a larger number of things we 
still do not understand. This project aims to fill in these gaps though characterizing the 
functional role of several different TERT and TR residues through mutational analysis. 
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Using the medaka TRBD and CR4/5 co-crystal to predict important interactions, we 
confirmed several residues in the medaka CR4/5 are vital for proper recognition and 
binding by the TERT protein. While the junction residue, A199, is absolutely conserved 
in TWJ structures from other TRs, the bulge residues, U182 and G189 , which mediate 
the specific interaction between medaka CR4/5 and TRBD are only conserved in closely 
related species, such as the fugu fish Takifugu rubripes (Podlevsky et al, 2008; Xie et al, 
2008). This is consistent with previous observations that fugu T/PK and CR4/5 domains 
can reconstitute telomerase activity with medaka TERT (Xie et al, 2008). In contrast, S. 
pombe TWJ contains a much shorter stem P6 with no bulged nucleotide, suggesting that 
S. pombe TRBD must recognize TWJ through some features that are different from U182 
and G189 of medaka CR4/5. Collectively, the structural and biochemical analyses 
suggest that CR4/5 (TWJ) is bound by TRBD through two types of interactions. The 
helical conformation of stems P6 and P6.1 and the conserved adenine at the junction 
J6/6.1 define the overall shape of CR4/5 (TWJ) essential for the TRBD-CR4/5 binding in 
all vertebrates and yeasts. The species-incompatibility of the TRBD-CR4/5 (TWJ) 
interaction presumably results from the co-evolution of the protein and RNA components 
of telomerase along different eukaryotic lineages.  
When structural information is not available, which is usually the case with 
human telomerase, mutagenesis can still be used to elucidate valuable data on the 
function of different regions of telomerase. By characterizing disease mutants, several 
novel residues have been discovered to be important for telomerase repeat addition 
processivity and show that this unique property of telomerase is important for in vivo 
function (Alder et al, 2011; Gramatges et al, 2013). In particular, several disease 
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mutations in the motif T domain of TERT have been shown to effect telomerase 
processivity (Gramatges et al, 2013). Through biochemical analysis of these mutants in 
our template free system, we found that the defects of the K570A mutant in repeat 
addition processivity is linked to an inability to possessively add nucleotides to an 
RNA/DNA duplex or to distinguish sequence of the bound duplex substrates. This 
interaction seems to be duplex specific and not dependent on sequence or length of the 
RNA overhang. Previously, correlation between duplex binding and enzyme processivity 
in telomerase has been shown with motif 3 mutants, but this is the first instance of a 
mutation where duplex translocation has been tied to repeat addition processivity. Taken 
together, these results have shed new light on how telomerase uses numerous unique 
protein and RNA interactions to regulate its complex catalytic cycle. 
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Figure S2.1: A telomeric template is sufficient for sequence defined pausing. (top) 
Sequences of RNA/DNA duplexes used. (bottom) Activity assay of in vitro reconstituted 
TF telomerase (upper panel) with various duplex substrates. Substrates were extended by 
the enzyme with α-32P-dGTP in the presence (+) or absence (-) of 1 mM dATP, dTTP, or 
dCTP as denoted above the gel. An α-32P end-labeled 5-mer oligonucleotide was used as 
a loading control (l.c.). The DNA primers GGGTTAGG (M1) or GCAACACC (M2) 
extended by one 32P-dGTP with terminal deoxynucleotidyl transferase (TdT) were 
included as size markers. 
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Figure S2.2: Alanine screening of hTERT residues with potential duplex interactions. 
Activity assays of various hTERT mutants reconstituted in vitro with template free 
telomerase RNA fragments for direct assay analysis. All reactions were performed with 5 
μM dGTP and 0.5 mM dATP. A 15-mer 32P-end-labeled oligonucleotide was included as 
a loading control (LC). 
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Figure S2.3: Effect of pseudoknot truncations on sequence dependent pausing. hTERT 
was in vitro reconstituted with various pseudoknot fragments (shown above gel). 
Resulting telomerase mutants were assayed with duplex substrates P1 or P4 in the 
presence of both α-32P-dGTP and 1 mM dATP. A 15-mer 32P-end-labeled oligonucleotide 
was included as a loading control (LC). 
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Figure S3.1: Native telomerases with permutated templates exhibit sequence-defined 
nucleotide addition pausing. Figure courtesy of Mingyi Xie. (top) Sequences of the DNA 
primers and the TR template variants assayed. Permuted templates (T1-T6) are flanked 
by guanosine (g) substitutions and the remaining TR (black line) sequence is shown. The 
sequence-defined pausing site (white arrowhead) and the physical template boundary 
(blue arrowhead) are denoted. (bottom) Activity assays for telomerase template 
permutation mutants. In vivo reconstituted telomerases with full-length hTR containing 
permuted templates were assayed with single-stranded DNA primers. A 32P end-labeled 
7-mer or 15-mer oligonucleotide was used as a loading control (l.c.). 
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Figure S3.2: Alanine screening of hTERT residues with potential duplex interactions. 
Activity assays of various hTERT mutants reconstituted in vitro with telomerase RNA 
fragments for direct assay analysis with telomeric primer 5’- (TTAGGG)3 -3’. A 15-mer 
32P-end-labeled oligonucleotide was included as a loading control (LC). 
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Figure S3.3: Activity assay of in vitro reconstituted telomerases that lack the sequence-
defined pausing signal or the P1-defined physical boundary. (right) Structure of 
pseudoknot structures used and sequences of the hTR template variants T1, T2, 49u and 
48u49u (AA). (left) Telomerase reconstituted in vitro with hTR with variants templates 
and/or P1 linker were assayed with the 18-mer DNA primer (TTAGGG)3 in the presence 
(+) or absence (-) of 0.5 mM dCTP. The secondary structure of full-length hTR (1-451) 
with P1 and truncated hTR (39-451) without P1 are shown above the gel. A 32P end-
labeled 15-mer oligonucleotide was used as a loading control (l.c.). 
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Figure S3.4: Evolutionary conservation of telomerase sequence-defined pausing. (A-C, 
left) Sequences of the DNA primers and the TR template variants assayed for S. 
purpuratus, N. crassa and T. Thermophilia, respectively. Sequence of permuted 
templates (T1-T6) are shown. (A-C, right) Sequence-defined pausing sites before (white 
arrowhead) and after (red arrowhead) template translocation are denoted. Activity assay 
for telomerase template permutation mutants. Substrates were labeled by the enzyme with 
α-32P-dGTP. A 32P end-labeled 18-mer oligonucleotide was used as a loading control 
(l.c.). 
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Figure S4.1: Sequence alignments of the CR4/5 (TWJ) domain of TR. Sequence 
alignment of the vertebrate CR4/5 domains and the fungi TWJ domains, based on predicted 
secondary structures. Conserved RNA secondary structures are denoted. The conserved 
nucleotide A at the junction J6/J6.1 as well as its interacting nucleotide G are highlighted in 
orange. 
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Figure S4.2: Titration of medaka CR4/5 RNA fragments. Medaka TERT was 
reconstituted with various concentrations of WT or mutant medaka CR4/5 fragments 
ranging from 0 to 500 nM. Concentrations of the pseudoknot fragment and all other 
reaction conditions were kept constant between trials. A 32P-end-labeled 15-mer 
oligonucleotide was used as a loading control (LC). 
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Abbreviation Meaning 
bp base pair 
CR4/5 Conserved Region 4 and 5 
CTE C-terminal extension 
DKC Dyskeratosis Congenita 
IFD insertion in fingers domain  
l.c. loading control 
NAP nucleotide addition processivity 
nt nucleotide 
POT1 protection of telomeres 1 
RAP repeat addition processivity 
RID RNA interacting domain 
RT Reverse transcriptase 
sca small cajal body-specific  
sno small nucleolar  
TBE template boundary element 
TEN telomerase N-terminal 
TERT Telomerase Reverse Transcriptase 
TF template-free 
TR Telomerase RNA 
TRBD telomerase RNA binding domain 
TWJ Three way junction 
VSR vertebrate specific region 
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